+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 9151

Chapter 9151 contains a list of PDF Full Texts available from EurekaMag.

Patt, S.; Gries, H.; Giraldo, M.; Cervos Navarro, J.; Martin, H.; Jaenisch, W.; Brockmoeller, J., 1996:
p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas

Watanabe, M.; Ushijima, T.; Kakiuchi, H.; Shiraishi, T.; Yatani, R.; Shimazaki, J.; Kotake, T.; Sugimura, T.; Nagao, M., 1994:
p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries

Kubo, Y.; Urano, Y.; Yoshimoto, K.; Iwahana, H.; Fukuhara, K.; Arase, S.; Itakura, M., 1994:
p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis

Munirajan, A.K.; Tutsumi-Ishii, Y.; Mohanprasad, B.K.; Hirano, Y.; Munakata, N.; Shanmugam, G.; Tsuchida, N., 1996:
p53 gene mutations in oral carcinomas from India

Zariwala, M.; Schmid, S.; Pfaltz, M.; Ohgaki, H.; Kleihues, P.; Schaefer, R., 1994:
P53 Gene mutations in oropharyngeal carcinomas: A comparison of solitary and multiple primary tumours and lymph-node metastases

Van Leeuwen, I.S.; Cornelisse, C.J.; Misdorp, W.; Goedegebuure, S.A.; Kirpensteijn, J.; Rutteman, G.R., 1997:
P53 Gene mutations in osteosarcomas in the dog

Felix, C.A.; Slavc, I.; Dunn, M.; Strauss, E.A.; Phillips, P.C.; Rorke, L.B.; Sutton, L.; Bunin, G.R.; Biegel, J.A., 1995:
P53 Gene mutations in pediatric brain tumors

Levy, A.; Hall, L.; Yeudall, W.A.drew; Lightman, S., L., 1994 :
P53 Gene mutations in pituitary adenomas: Rare events

Zhang, S.; Feng, X.; Koga, H.; Ichikawa, T.; Abe, S.; Kumanishi, T., 1993:
P53 Gene mutations in pontine gliomas of juvenile onset

Fogelfeld, L.; Bauer, T.K.; Schneider, A.B.; Swartz, J.E.; Zitman, R., 1996:
p53 gene mutations in radiation-induced thyroid cancer

Bosari, S.; Viale, G.; Roncalli, M.; Graziani, D.; Borsani, G.; Lee, A.K.; Coggi, G., 1995:
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma

Costa, A.; Marasca, R.; Valentinis, B.; Savarino, M.; Faranda, A.; Silvestrini, R.; Torelli, G., 1995:
p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers

Binks, S.; Clelland, C.A.; Ronan, J.; Bell, J., 1997:
p53 gene product expression in resected non-small cell carcinoma of the lung, with studies of concurrent cytological preparations and microwave antigen retrieval

Mullick, S.S.; Green, L.K.; Ramzy, I.; Brown, R.W.; Smith, D.; Gondo, M.M.; Cagle, P.T., 1996:
p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells

Hernández, A.; Hernández, P.; Corral, L.; Muñiz, A.; Alaez, C.; Espinosa, E.; Fernández, O.; Martinez, G., 1993:
p53 gene rearrangements in chronic myelocytic leukemia

Ambros, R.A.; Ross, J.S.; Kallakury, B.V.S.; Malfetano, J.; Kim, Y.; Hwang, J.; Breese, K.; Figge, J., 1995:
P53 Gene status in endometrial carcinoma showing diffuse positivity for p53 protein by immunohistochemical analysis

Gazzeri, S.; Brambilla, E.; Caron, D.F.omentel, C.; Gouyer, V.; Moro, D.; Perron, P.; Berger, F.; Brambilla, C., 1994:
P53 Genetic abnormalities and myc activation in human lung carcinoma

Weston, A.; Pan, C.F.; Ksieski, H.B.; Wallenstein, S.; Berkowitz, G.S.; Tartter, P.I.; Bleiweiss, I.J.; Brower, S.T.; Senie, R.T.; Wolff, M.S., 1997:
p53 haplotype determination in breast cancer

Prendergst, N.J.; Atkins, M.R.; Schatte, E.C.; Paulson, D.F.; Walther, P.J., 1996:
P53 Immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma

Itoi, T.; Watanabe, H.; Yoshida, M.; Kasuya, K.; Yokota, Y., 1995:
P53 Immunohistochemistry of Gallbladder Carcinoma: A Comparison of PAb1801 and D07 Antibodies

Tenaud, C.; Negoescu, A.; Labat-Moleur, F.; Legros, Y.; Soussi, T.; Brambilla, E., 1994:
p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinomas

Goukon, Yuji; Sasano, Hironobu; Nishihira, Tetsuro; Mori, Shozo; Nagura, Hiroshi, 1994:
P53 Immunolocalization in cytology specimens: A study in human esophageal carcinoma

Ojanguren, I.; Castellà, E.; Llatjós, M.; Ariza, A.; Navas Palacios, J.J., 1996:
p53 immunoreaction in hepatocellular carcinoma and its relationship to etiologic factors. A fine needle aspiration study

Jeffers, M.D.; Farquharson, M.A.; Richmond, J.A.; McNicol, A.M., 1995:
p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus

Stattin, P.; Bergh, A.; Karlberg, L.; Nordgren, H.; Damber, J.E., 1996:
p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer

Rice, T.W.; Goldblum, J.R.; Falk, G.W.; Tubbs, R.R.; Kirby, T.J.; Casey, G., 1994:
p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma

Casson, A.G.; Kerkvliet, N.; O'malley, F.; Inculet, R.; Troster, M., 1994:
P53 Immunoreactivity in carcinosarcoma of the esophagus

Ojanguren, I.; Ariza, A.; Castella, E.M.; Fernandez Vasalo, A.; Mate, J.L.; Navas Palacios, J.J., 1995:
P53 Immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma

Bosari, S.; Roncalli, M.; Viale, G.; Bossi, P.; Coggi, G., 1993:
p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix

Hughes, J.H.; Cohen, M.B.; Robinson, R.A., 1995:
p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma

Mcgregor, J.M.; Dublin, E.A.; Levison, D.A.; Macdonald, D.M.; Smith, N.P.; Whittaker, S., 1995:
P53 Immunoreactivity is uncommon in primary cutaneous lymphoma

Garzetti, G.G.; Ciavattini, A.; Lucarini, G.; Goteri, G.; De Nictolis, M.; Fabris, G.; Biagini, G., 1997:
p53 immunostaining and HPV DNA detection by PCR in cervical intraepithelial neoplasia: clinical implications of a combinated evaluation

Munck Wikland, E.; Kuylenstierna, R.; Lindholm, J.; Auer, G., 1997:
P53 Immunostaining and image cytometry DNA analysis in precancerous and cancerous squamous epithelial lesions of the larynx

Oohashi, Y.; Watanabe, H.; Ajioka, Y.; Hatakeyama, K., 1995:
P53 Immunostaining distinguishes malignant from benign lesions of the gall-bladder

Ledet, S.C.; Brown, R.W.; Cagle, P.T., 1995:
p53 immunostaining in the differentiation of inflammatory pseudotumor from sarcoma involving the lung

Carbone, D.P.; Mitsudomi, T.; Chiba, I.; Piantadosi, S.; Rusch, V.; Nowak, J.A.; McIntire, D.; Slamon, D.; Gazdar, A.; Minna, J., 1994:
p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871

Shao, Z.M.; Dawson, M.I.; Li, X.S.; Rishi, A.K.; Sheikh, M.S.; Han, Q.X.; Ordonez, J.V.; Shroot, B.; Fontana, J.A., 1995:
p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells

Shao, Z.; Jiang, M.; Yu, L.; Han, Q.; Shen, Z., 1997:
p53 independent G1 arrest and apoptosis induced by adriamycin

Miller, S.D.; Farmer, G.; Prives, C., 1995:
p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner

Campomenosi, P.; Conio, M.; Bogliolo, M.; Urbini, S.; Assereto, P.; Aprile, A.; Monti, P.; Aste, H.; Lapertosa, G.; Inga, A.; Abbondandolo, A.; Fronza, G., 1996:
p53 is frequently mutated in Barrett's metaplasia of the intestinal type

Stürzbecher, H.W.; Donzelmann, B.; Henning, W.; Knippschild, U.; Buchhop, S., 1996:
p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction

Sauter, E.R.; Cleveland, D.; Trock, B.; Ridge, J.A.; Klein-Szanto, A.J., 1994:
p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium

Milne, D.M.; Campbell, L.E.; Campbell, D.G.; Meek, D.W., 1995:
p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1

Nikiforov, M.A.; Hagen, K.; Ossovskaya, V.S.; Connor, T.M.; Lowe, S.W.; Deichman, G.I.; Gudkov, A.V., 1996:
p53 modulation of anchorage independent growth and experimental metastasis

Okita, S.; Tsutsumi, M.; Onji, M.; Konishi, Y., 1995:
P53 Mutation Without Allelic Loss and Absence of mdm-2 Amplification in a Transplantable Hamster Pancreatic Ductal Adenocarcinoma and Derived Cell Lines but Not Primary Ductal Adenocarcinomas in Hamsters

Kido, A.; Tsujiuchi, T.; Tsutsumi, M.; Takahama, M.; Okajima, E.; Kobitsu, K.; Miyauchi, Y.; Mii, Y.; Tamai, S.; Konishi, Y., 1997:
p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats

Koch, W.M.; Brennan, J.A.; Zahurak, M.; Goodman, S.N.; Westra, W.H.; Schwab, D.; Yoo, G.H.; Lee, D.J.n; Forastiere, A.A.; Sidransky, D., 1996:
P53 Mutation and locoregional treatment failure in head and neck squamous cell carcinoma

Bennett, W.P.; Hollstein, M.C.; Metcalf, R.A.; Welsh, J.A.; He, A.; Zhu, S.M.; Kusters, I.; Resau, J.H.; Trump, B.F.; Lane, D.P., 1992:
p53 mutation and protein accumulation during multistage human esophageal carcinogenesis

Brachman, D.G.; Beckett, M.; Graves, D.; Haraf, D.; Vokes, E.; Weichselbaum, R.R., 1993:
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines

Fujii, T.; Oguni, S.; Kikuchi, M.; Kanai, N.; Saito, K., 1995:
P53 Mutation in carcinomas arising in ovarian cystic teratomas

Uchino, S.; Noguchi, M.; Ochiai, A.; Saito, T.; Kobayashi, M.; Hirohashi, S., 1993:
P53 Mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancer

Balcer Kubiczek, E.K.; Yin, J.; Lin, K.; Harrison, G.H.; Abraham, J.M.; Meltzer, S.J., 1995:
P53 Mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons

Holstein, M.C.; Wild, C.P.; Bleicher, F.; Chutimataewin, S.; Harris, C.C.; Srivatanakul, P.; Montesano, R., 1993:
P53 Mutations and aflatoxin B-1 exposure in hepatocellular carcinoma patients from Thailand

Kim, Y.-Tak; Thomas, N., F.; Kessis, T., D.; Wilkinson, E., J.; Hedrick, L.; Cho, K., R., 1996:
p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas

Harty, L.C.; Guinee, D.G.; Travis, W.D.; Bennett, W.P.; Jett, J.; Colby, T.V.; Tazelaar, H.; Trastek, V.; Pairolero, P.; Liotta, L.A.; Harris, C.C.; Caporaso, N.E., 1996:
p53 mutations and occupational exposures in a surgical series of lung cancers

Lo Coco, F.; Gaidano, G.; Louie, D.C.; Offit, K.; Chaganti, R.S.; Dalla-Favera, R., 1993:
p53 mutations are associated with histologic transformation of follicular lymphoma

Casey, G.; Yamanaka, Y.; Friess, H.; Kobrin, M.S.; Lopez, M.E.; Buchler, M.; Beger, H.G.; Korc, M., 1993:
P53 Mutations are common in pancreatic cancer and are absent in chronic pancreatitis

O'Malley, F.P.; Vnencak-Jones, C.L.; Dupont, W.D.; Parl, F.; Manning, S.; Page, D.L., 1994:
p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data

Benhattar, J.; Cerottini, J.P.; Saraga, E.; Metthez, G.; Givel, J.C., 1996:
p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas

Hollstein, M.; Marion, M.J.; Lehman, T.; Welsh, J.; Harris, C.C.; Martel-Planche, G.; Kusters, I.; Montesano, R., 1994:
p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers

Neshat, K.; Sanchez, C.A.; Galipeau, P.C.; Blount, P.L.; Levine, D.S.; Joslyn, G.; Reid, B.J., 1994:
p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia

Kusser, W.C.; Miao, X.; Glickman, B.W.; Friedland, J.M.; Rothman, N.; Hemstreet, G.P.; Mellot, J.; Swan, D.C.; Schulte, P.A.; Hayes, R.B., 1994:
P53 Mutations in Human Bladder Cancer

Kanjilal, S.; Strom, S.S.; Clayman, G.L.; Weber, R.S.; el-Naggar, A.K.; Kapur, V.; Cummings, K.K.; Hill, L.A.; Spitz, M.R.; Kripke, M.L., 1995:
p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization

Zou, M.; Shi, Y.; Farid, N.R., 1993:
p53 mutations in all stages of thyroid carcinomas

Cooper, M.J.; Haluschak, J.J.; Johnson, D.; Schwartz, S.; Morrison, L.J.; Lippa, M.; Hatzivassiliou, G.; Tan, J., 1994:
p53 mutations in bladder carcinoma cell lines

Masui, T.; Don, I.; Takada, N.; Ogawa, K.; Shirai, T.; Fukushima, S., 1994:
p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine

Liang, Yuan Yuan; Esteve, Asuncion; Martel Planche, Ghyslaine; Takahashi, Satoru; Lu, Shih Hsin; Montesano, Ruggero; Hollstein, Monica, 1995:
P53 Mutations in esophageal tumors from high-incidence areas of China

Recio, L.; Sisk, S.; Pluta, L.; Bermundez, E.; Gross, E.A.; Chen, Z.; Morgan, K.; Walker, C., 1992:
P53 Mutations in formaldehyde-induced nasal squamous cell carcinoma in rats

Schneider, B.G.; Hilsenbeck, S.G.; Hensel, C.H.; Pekkel, V.; Shelton, C.H.; Rodriguez Martinez, H.A.; Gutierrez Diaz, C.M.E.ther; Pulitzer, D.R.; Allred, D.C.aig, 1994:
P53 Mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos

Olshan, A.F.; Weissler, M.C.; Pei, H.; Conway, K., 1997:
p53 mutations in head and neck cancer: new data and evaluation of mutational spectra

Lazarus, P.; Idris, A.M.; Kim, J.; Calcagnotto, A.; Hoffmann, D., 1996:
p53 mutations in head and neck squamous cell carcinomas from Sudanese snuff (toombak) users

Lehman, T.A.; Modali, R.; Boukamp, P.; Stanek, J.; Bennett, W.P.; Welsh, J.A.; Metcalf, R.A.; Stampfer, M.R.; Fusenig, N., 1993:
P53 Mutations in human immortalized epithelial cell lines

Hamelin, R.; Zucman, J.; Melot, T.; Delattre, O.; Thomas, G., 1994:
P53 Mutations in human tumors with chimeric EWS/FLI-1 genes

Ryberg, D.; Kure, E.; Lystad, S.; Skaug, V.; Stangeland, L.; Mercy, I.; Borresen, A.-Lise; Haugen, A., 1994:
P53 Mutations in lung tumors: Relationship to putative susceptibility markers for cancer

Greiner, T.C.; Moynihan, M.J.; Chan, W.C.; Lytle, D.M.; Pedersen, A.; Anderson, J.R.; Weisenburger, D.D., 1996:
p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis

Ozbun, M.A.; Medina, D.; Butel, J.S., 1993:
p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo

Kappes, S.; Milde Langosch, K.; Kressin, P.; Passlack, B.; Dockhorn Dworniczak, B.; Roehlke, P.; Loening, T., 1995:
P53 Mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry

Soini, Y.; Welsh, J.A.; Ishak, K.G.; Bennett, W.P., 1995:
p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure

Scholes, A.G.M.; Liloglou, T.; Snijders, P.J.F.; Hart, C.A.thony; Jones, A.S.; Woolgar, J.A.; Vaughan, E.D.vid; Walboomers, J.M.M.; Field, J.K., 1997:
P53 Mutations in relation to human papillomavirus type 16 infection in squamous cell carcinoma of the head and neck

Liloglou, T.; Scholes, A.G.; Spandidos, D.A.; Vaughan, E.D.; Jones, A.S.; Field, J.K., 1997:
p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability

Konishi, N.; Hiasa, Y.; Hayashi, I.; Matsuda, H.; Tsuzuki, T.; Ming, T.; Kitahori, Y.; Shiraishi, T.; Yatani, R.; Shimazaki, J., 1995:
p53 mutations occur in clinical, but not latent, human prostate carcinoma

Ozbun, M.A.; Jerry, D.J.; Kittrell, F.S.; Medina, D.; Butel, J.S., 1993:
p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro

Russell, S.J.; Ye, Y.W.i; Waber, P.G.; Shuford, M.; ScholdS.C.ifford, J.; Nisen, P.D., 1995:
P53 Mutations, O-6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors

Lunn, R.M.; Zhang, Y.J.; Wang, L.Y.; Chen, C.J.; Lee, P.H.; Lee, C.S.; Tsai, W.Y.; Santella, R.M., 1997:
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan

Knippschild, U.; Milne, D.; Campbell, L.; Meek, D., 1996:
p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage

Esrig, D.; Spruck, C.H.; Nichols, P.W.; Chaiwun, B.; Steven, K.; Groshen, S.; Chen, S.C.; Skinner, D.G.; Jones, P.A.; Cote, R.J., 1993:
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer

Beylot-Barry, M.; Vergier, B.; DeMascarel, A.; Beylot, C.; Merlio, J.P., 1995:
p53 oncoprotein expression in cutaneous lymphoproliferations

Gallo, O.; Franchi, A.; Bianchi, S.; Boddi, V.; Giannelli, E.; Alajmo, E., 1995:
P53 Oncoprotein Expression in Parotid gland Carcinoma Is Associated with Clinical Outcome

Kerschmann, R.L.; McCalmont, T.H.; LeBoit, P.E., 1994:
p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma

Dolcetti, R.; Doglioni, C.; Maestro, R.; Gasparotto, D.; Barzan, L.; Pastore, A.; Romanelli, M.; Boiocchi, M., 1992:
P53 Over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: Genetic and prognostic implications

Chang, F.; Syrjänen, S.; Wang, L.; Shen, Q.; Syrjänen, K., 1997:
p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China

Kanai, T.; Konno, H.; Maruyama, K.; Baba, M.; Tanaka, T.; Maruo, Y.; Nishino, N.; Nakamura, S.; Baba, S.; Sugimura, H., 1997:
p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer

Chang, K.H.; Kwon, J.W.; Kim, B.S.; Hwang, J.H.; Lee, S.K.; Lee, Y.C.; Park, H.J.; Park, I.S.; Kim, H.K., 1997:
P53 overexpression in gastric adenocarcinoma with Helicobacter pylori infection

Goukon, Y.; Sasano, H.; Nishihira, T.; Nagura, H.; Mori, S., 1994:
p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study

Barbatis, C.; Loukas, L.; Grigoriou, M.; Nikolaou, I.; Tsikou-Papafragou, A.; Marsan, N.; Gatter, K.C.; Kaklamanis, L., 1995:
p53 Overexpression in laryngeal squamous cell carcinoma and dysplasia

Orazi, A.; Kahsai, M.; John, K.; Neiman, R.S., 1996:
p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis

Zhang, L.; Mao, E.; Priddy, R.; Rosin, M., 1996:
p53 overexpression in oral lichen planus

Parenti, A.R.; Rugge, M.; Frizzera, E.; Ruol, A.; Noventa, F.; Ancona, E.; Ninfo, V., 1995:
p53 overexpression in the multistep process of esophageal carcinogenesis

Yin, J.; Harpaz, N.; Tong, Y.; Huang, Y.; Laurin, J.; Greenwald, B.D.; Hontanosas, M.; Newkirk, C.; Meltzer, S.J., 1993:
p53 point mutations in dysplastic and cancerous ulcerative colitis lesions

Sato, T.; Yuyama, Y.; Watabe, K.; Takahashi, K.; Okazaki, A.; Denno, R.; Toda, K.; Okazaki, M.; Hirata, K., 1995:
P53 Point mutations in fine-needle aspirated breast cancer cells and their DNA ploidy patterns

Harpaz, N.; Peck, A.L.; Yin, J.; Fiel, I.; Hontanosas, M.; Tong, T.R.; Laurin, J.N.; Abraham, J.M.; Greenwald, B.D.; Meltzer, S.J., 1994:
p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma

Diamantis, I.; Karamitopoulou, E.; Perentes, E.; Zimmermann, A., 1995:
P53 Protein Immunoreactivity in Extrahepatic Bile Duct and Gallbladder Cancer: Correlation With Tumor Grade and Survival

Bennett, W.P.; Colby, T.V.; Travis, W.D.; Borkowski, A.; Jones, R.T.; Lane, D.P.; Metcalf, R.A.; Samet, J.M.; Takeshima, Y.; Gu, J.R., 1993:
p53 protein accumulates frequently in early bronchial neoplasia

Anker, L.; Ohgaki, H.; Ludeke, B.I.; Herrmann, H.D.etrich; Kleihues, P.; Westphal, M., 1993:
P53 Protein accumulation and gene mutations in human glioma cell lines

Elledge, R.M.; Clark, G.M.; Fuqua, S.A.; Yu, Y.Y.; Allred, D.C., 1994:
p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer

Younes, M.; Lebovitz, R.M.; Lechago, L.V.; Lechago, J., 1993:
p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study

Bourdon, J.C.ristophe; D'errico, A.; Paterlini, P.; Grigioni, W.; May, E.; Debuire, B., 1995:
P53 Protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation

Nuorva, K.; Mäkitaro, R.; Huhti, E.; Kamel, D.; Vähäkangas, K.; Bloigu, R.; Soini, Y.; Pääkkö, P., 1994:
p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke

Younes, M.; Riley, S.; Genta, R.M.; Mosharaf, M.; Mody, D.R., 1995:
P53 Protein accumulation in tumors of the ampulla of vater

Younes, M.; Ertan, A.; Lechago, L., V.; Somoano, J., R.; Lechago, J., 1997:
P53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia

Salem, C.E.; Tomasic, N.A.; Elmajian, D.A.; Esrig, D.; Nichols, P.W.; Taylor, C.R.; Skinner, D.G.; Roy Burman, P.; Lieskovsky, G.; Cote, R.J., 1997:
P53 Protein and gene alterations in pathological stage C prostate carcinoma

Lakshmi, S.; Nair, M.B.; Jayaprakash, P.G.; Rajalekshmy, T.N.; Nair, M.K.; Pillai, M.R., 1997:
p53 protein and tumorigenesis in the uterine cervix

Klemi, P.J.; Pylkkänen, L.; Kiilholma, P.; Kurvinen, K.; Joensuu, H., 1995:
p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

Mummenbrauer, T.; Janus, F.; Mueller, B.; Wiesmueller, L.; Deppert, W.; Grosse, F., 1996:
P53 Protein exhibits 3'-to-5' exonuclease activity

Sarbia, M.; Porschen, R.; Borchard, F.; Horstmann, O.; Willers, R.; Gabbert, H.E., 1994:
P53 Protein expression and prognosis in squamous cell carcinoma of the esophagus

Gupta, R.K.; Norton, A.J.; Lister, T.A.; Bodmer, J.G., 1993:
p53 protein expression in Reed-Sternberg cells of Hodgkin's disease

Ingle, R.R.; Setzen, G.; Koltai, P.J.; Monte, D.; Pastore, J.; Jennings, T.A., 1997:
p53 protein expression in benign lesions of the upper respiratory tract

Lipponen, P.; Ji, H.; Aaltomaa, S.; Syrjanen, S.; Syrjanen, K., 1993:
P53 Protein expression in breast cancer as related to histopathological characteristics and prognosis

Giannikaki, E.; Kouvidou, C.; Tzardi, M.; Stefanaki, K.; Koutsoubi, K.; Gregoriou, M.; Zois, E.; Kakolyris, S.; Mavroudi, C.; Delides, G.; Georgoulias, V.; Kanavaros, P., 1997:
p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1

Lee, Y.C.; Song, S.Y.; Chung, J.B.; Kang, J.K.; Park, I.S., 1996:
p53 protein expression in extrahepatic bile duct cancer

Hazar, B.; Paydaş, S.; Zorludemir, S.; Sahin, B.; Tuncer, I., 1997:
p53 protein expression in gastrointestinal lymphomas

Poller, D.N.; Hutchings, C.E.; Galea, M.; Bell, J.A.; Nicholson, R.A.; Elston, C.W.; Blamey, R.W.; Ellis, I.O., 1992:
P53 Protein expression in human breast carcinoma: Relationship to expression of epidermal growth factor receptor, c-erbB-e protein overexpression, and oestrogen receptor

Pruneri, G.; Pignataro, L.; Fracchiolla, N.S.; Ferrero, S.; Capaccio, P.; Carboni, N.; Ottaviani, A.; Maiolo, A.T.; Neri, A.; Buffa, R., 1996:
P53 Protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 gene

Crosthwaite, N.; Teale, D.; Franklin, C.; Foster, G.A.; Stringer, B.M., 1996:
p53 protein expression in malignant, pre-malignant and non-malignant lesions of the lip

Cristofolini, M.; Boi, S.; Girlando, S.; Zumiani, G.; Cristofolini, P.; Dalla Palma, P.; Doglioni, C.; Barbareschi, M., 1993:
p53 Protein expression in nevi and melanomas

Tzardi, M.; Kouvidou, C.; Panayiotides, I.; Stefanaki, K.; Rontogianni, D.; Zois, E.; Koutsoubi, K.; Eliopoulos, G.; Delides, G.; Kanavaros, P., 1996:
p53 protein expression in non-Hodgkin's lymphoma. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1

Hutson, R.; Ramsdale, J.; Wells, M., 1995:
P53 Protein expression in putative precursor lesions of epithelial ovarian cancer

Oram, Y.; Orengo, I.; Baer, S.C.; Ocal, T., 1994:
p53 Protein expression in squamous cell carcinomas from sun-exposed and non-sun-exposed sites

Pizarro, A.; Gamallo, C.; Castresana, J.S.; Gomez, L.; Palacios, J.; Benito, N.; Espada, J.; Fonseca, E.; Contreras, F., 1995:
P53 Protein expression in viral warts from patients with epidermodysplasia verruciformis

Lee, C.S.; Pirdas, A., 1995:
p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater

Sadoul, R.; Quiquerez, A.L.; Martinou, I.; Fernandez, P.A.; Martinou, J.C., 1996:
P53 Protein in sympathetic neurons: Cytoplasmic localization and no apparent function in apoptosis

Cho, M.Y.; Jung, S.H.; Kim, T.S., 1995:
p53 protein overexpression in astrocytic neoplasms

Levi, E.; Stryker, S.J.; Rao, M.S., 1996:
p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?

Kohlberger, P.; Gitsch, G.; Loesch, A.; Tempfer, C.; Kaider, A.; Reinthaller, A.; Kainz, C.; Breitenecker, G., 1996:
p53 protein overexpression in early stage endometrial cancer

Wistuba, I., I.; Roa, A., F.V.-Gazdaran; Albores-Saavedra, J., 1996:
p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study

Poljak, M.; Gale, N.; Kambic, V.; Luzar, B., 1997:
p53 protein overexpression in laryngeal squamous cell papillomas

Niemann, T.H.; Raab, S.S.; Lenel, J.C.; Rodgers, J.R.; Robinson, R.A., 1995:
p53 protein overexpression in smooth muscle tumors of the uterus

Noel, J.C.; Peny, M.O.; D.D.bbeleer, G.; Thiriar, S.; Fayt, I.; Haot, J.; Heenen, M., 1996:
p53 Protein overexpression in verrucous carcinoma of the skin

Kagie, M.J.; Kenter, G.G.; Tollenaar, R.A.E.M.; Hermans, J.; Trimbos, J.B.ptist; Fleuren, G.J.n, 1997:
P53 Protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva

Kagie, M.J.; Kenter, G.G.; Tollenaar, R.A.; Hermans, J.; Trimbos, J.P.; Fleuren, G.J., 1997:
p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter

Czyz, W.; Joensuu, H.; Pylkkänen, L.; Klemi, P.J., 1994:
p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland

Charpin, C.; Devictor, B.; Andrac, L.; Amabile, J.; Bergeret, D.; Lavaut, M.N.elle; Allasia, C.; Piana, L., 1995:
p53 quantitative immunocytochemical analysis in breast carcinomas

Sandri, M.I.; Isaacs, R.J.; Ongkeko, W.M.; Harris, A.L.; Hickson, I.D.; Broggini, M.; Vikhanskaya, F., 1996:
p53 regulates the minimal promoter of the human topoisomerase IIalpha gene

Han, J.W.n; Dionne, C.A.; Kedersha, N.L.; Goldmacher, V.S., 1997:
P53 Status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expression c-Myc

Horesovsky, G.; Recio, L.; Everitt, J.; Goldsworthy, T.; Wolf, D.C.; Walker, C., 1995:
P53 Status in spontaneous and dimethylnitrosamine-induced renal cell tumors from rats

Jansson, T.; Inganäs, M.; Sjögren, S.; Norberg, T.; Lindgren, A.; Holmberg, L.; Bergh, J., 1995:
p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings

Shin, T.H.; Paterson, A.J.; Kudlow, J.E., 1995:
p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53

Maiyar, A.C.; Huang, A.J.; Phu, P.T.; Cha, H.H.; Firestone, G.L., 1996:
p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells

Runnebaum, I.B.; Kreienberg, R., 1995:
p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapy

Park, D.J.; Chumakov, A.M.; Miller, C.W.; Pham, E.Y.; Koeffler, H.P., 1996:
p53 transactivation through various p53-responsive elements

Thut, C.J.; Chen, J.L.; Klemm, R.; Tjian, R., 1995:
p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60

Rovira, A.; Urbano-Ispizua, A.; Cervantes, F.; Rozman, M.; Vives-Corrons, J.L.; Montserrat, E.; Rozman, C., 1995:
P53 Tumor suppressor gene in chronic myelogenous leukemia: A sequential study

Bremer, G., L.; Tieboschb, A., T.M.G.; Van-Der-Putten, H., W.H.M.; De-Haan, J.; Arends, J.-Willem, 1995:
P53 Tumor suppressor gene protein expression in cervical cancer: Relationship to prognosis

Gibson, G.E.; O'grady, A.; Kay, E.W.; Leader, M.; Murphy, G.M., 1997:
P53 Tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients

Kahlenberg, M.S.; Stoler, D.L.; Basik, M.; Petrelli, N.J.; Rodriguez-Bigas, M.; Anderson, G.R., 1996:
p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers

Lens, D.; D.S.houwer, P.J.; Hamoudi, R.A.; Abdul-Rauf, M.; Farahat, N.; Matutes, E.; Crook, T.; Dyer, M.J.; Catovsky, D., 1997:
p53 abnormalities in B-cell prolymphocytic leukemia

Kazachkov, Y.; Khaoustov, V.; Yoffe, B.; Solomon, H.; Klintmalm, G.B.; Tabor, E., 1996:
p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons

Lim, B.H.; Soong, R.; Grieu, F.; Robbins, P.D.; House, A.K.; Iacopetta, B.J., 1996:
p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma

Wiethege, T.; Voss, B.; Mueller, K.M., 1995:
P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer

Wiethege, T.; Voss, B.; Mueller, K.M., 1994:
P53 accumulation in polynuclear-giant-cells

Schmitz Draeger, B.J.; Van Roeyen, C.R.C.; Grimm, M.O.; Gerharz, C.D.; Decken, K.; Schulz, W.A.; Bueltel, H.; Makri, D.; Ebert, T.; Ackermann, R., 1994:
P53 accumulation in precursor lesions and early stages of bladder cancer

Bombardieri, E.; Seregni, E.; Daidone, M.G.; Benini, E.; Massaron, S.; Ferrari, L.; D.F.onzo, G.; Silvestrini, R., 1998:
P53 accumulation in primary breast cancer: a comparison between immunohistochemistry and a novel luminometric immunoassay

Wang, X.; Matsumoto, H.; Takahashi, A.; Nakano, T.; Okaichi, K.; Ihara, M.; Ohnishi, T., 1996:
P53 accumulation in the organs of low-dose X-ray-irradiated mice

Raitanen, M.P.; Tammela, T.L.J.; Kallioinen, M.; Isola, J., 1997:
P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer

Liebetrau, W.; Budde, A.; Savoia, A.; Grummt, F.; Hoehn, H., 1997 :
p53 activates Fanconi anemia group C gene expression

Wallingford, J.B.; Seufert, D.W.; Virta, V.C.; Vize, P.D., 1997:
P53 activity is essential for normal development in Xenopus

A.S.rraj, S.; Bridges, R.; Cawkwell, L.; Lewis, F.A.; Quirke, P., 1995:
P53 allelic imbalance in astrocytoma detected using fluorescent PCR of microsatellite repeat polymorphisms

Skilling, J.S.; Powills, K.; Lager, D.J.; Anderson, B.; Sorosky, J.; Buller, R.E., 1996:
p53 allelotypes and enhanced detection of allelic loss in ovarian cancer: lack of correlation with familial and clinical factors

Caruana, S.M.; Zwiebel, N.; Cocker, R.; Mccormick, S.A.; Eberle, R.C.; Lazarus, P., 1997:
p53 alteration and human papilloma virus infection in paranasal sinus cancer

Sasa, M.; Kondo, K.; Komaki, K.; Morimoto, T.; Monden, Y., 1994:
P53 alteration correlates with negative ER, Negative PgR, and high histologic grade in breast cancer

Abbas, A.; Kukreti, R.; Naik, S.; Therwath, A., 1997:
p53 alterations in breast cancer of the Parsi ethnic group

Seruca, R.; David, L.; Castedo, S.; Veiga, I.; Borresen, A.-Lise; Sobrinho-Simones, M., 1994:
P53 alterations in gastric carcinoma: A study of 56 primary tumors and 204 nodal metastases

Caamano, J.; Zhang, S.Y.; Rosvold, E.A.; Bauer, B.; Klein-Szanto, A.J., 1993:
p53 alterations in human squamous cell carcinomas and carcinoma cell lines

Bennett, W.P., 1995:
p53 alterations in progenitor lesions of the bronchus, esophagus, oral cavity, and colon

Blum, D.; Wu, Y.; Nissou, M.F.ance; Arnaud, S.; Benabid, A.L.uis; Verna, J.M.rc, 1997:
P53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells

Mulder, J.W.; Wielenga, V.J.; Pals, S.T.; Offerhaus, G.J., 1997:
p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis

May, P.; May, E., 1995:
P53 and cancers

Eltabbakh, G.H.; Belinson, J.L.; Kennedy, A.W.; Biscotti, C.V.; Casey, G.; Tubbs, R.R., 1997:
p53 and HER-2/neu overexpression in ovarian borderline tumors

Chang, K.W.; Lin, S.C.; Koos, S.; Pather, K.; Solt, D., 1996:
p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas

Kalthoff, H.; Schmiegel, W.; Roeder, C.; Kasche, D.; Schmidt, A.; Lauer, G.; Thiele, H.G.; Honold, G.; Pantel, K.; Riethmüller, G., 1993:
p53 and K-RAS alterations in pancreatic epithelial cell lesions

McDonald, J.W.; Taylor, J.A.; Watson, M.A.; Saccomanno, G.; Devereux, T.R., 1995:
p53 and K-ras in radon-associated lung adenocarcinoma

Holst, V.A.; Finkelstein, S.; Colby, T.V.; Myers, J.L.; Yousem, S.A., 1997:
p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis

Girod, S.C.; Krueger, G.; Pape, H.D., 1993:
P53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa

Takei, K.; Watanabe, H.; Itoi, T.; Saito, T., 1996:
P53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder

Teneriello, M.G.; Ebina, M.; Linnoila, R.I.; Henry, M.; Nash, J.D.; Park, R.C.; Birrer, M.J., 1993:
p53 and Ki-ras gene mutations in epithelial ovarian neoplasms

Lonardo, F.; Ueda, T.; Huvos, A., G.; Healey, J.; Ladanyi, M., 1997:
P53 and MDM2 alterations in osteosarcomas: Correlation with clinicopathologic features and proliferative rate

Matsumura, T.; Yoshihama, Y.; Kimura, T.; Shintani, S.; Alcalde, R.E., 1996:
p53 and MDM2 expression in oral squamous cell carcinoma

Pacinda, S.J.; Ledet, S.C.; Gondon, M.M.; Langston, C.; Brown, R.W.; Carmona, P.A.; Franklin, R.B.; Roggli, V.L.; Cagle, P.T., 1996:
p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas

Abo, J.; Inokuchi, K.; Dan, K.; Nomura, T., 1993:
p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia

El-Habashi, A.H.; Freeman, S.M.; El-Morsi, B.; Morris, G.F.; Marrogi, A., J., 1996:
P53 and PCNA coexpression of 81 pleural and peritoneal effusion specimens: An immunohistochemical study

Paradiso, A.; Rabinovich, M.; Vallejo, C.; Machiavelli, M.; Romero, A.; Perez, J.; Lacava, J.; Cuevas, M.A.; Rodriquez, R.; Leone, B.; Sapia, M.G.; Simone, G.; De Lena, M., 1996:
p53 and PCNA expression in advanced colorectal cancer: response to chemotherapy and long-term prognosis

Ariza, A.; Mate, J.L.; Fernandez Vasalo, A.; Gomez Plaza, C.; Perez Piteira, J.; Pujol, M.; Navas Palacios, J.J., 1994:
p53 and proliferating cell nuclear antigen expression in JC virus-infected cells of progressive multifocal leukoencephalopathy

Portier, M.; Molès, J.P.; Mazars, G.R.; Jeanteur, P.; Bataille, R.; Klein, B.; Theillet, C., 1992:
p53 and RAS gene mutations in multiple myeloma

Jahnson, S.; Risberg, B.; Karlsson, M.G.; Westman, G.; Bergström, R.; Pedersen, J., 1995:
p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy

Martin, D.W.; Subler, M.A.; Muñoz, R.M.; Brown, D.R.; Deb, S.P.; Deb, S., 1993:
p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding protein

Gualberto, A.; Baldwin, A.S., 1995:
p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat

Yin, M.B.; Voigt, W.; Panadero, A.; Vanhoefer, U.; Frank, C.; Pajovic, S.; Azizkhan, J.; Rustum, Y.M., 1997:
p53 and WAF1 are induced and Rb protein is hypophosphorylated during cell growth inhibition by the thymidylate synthase inhibitor ZD1694 (Tomudex)

Nakashima, T.; Nakashima, T.; Masuda, M.; Komiyama, S., 1997:
p53 and bcl-2 expression and argyrophilic nucleolar organizer regions in patients with malignant maxillary sinus tumours

Silvestrini, R.; Benini, E.; Veneroni, S.; Daidone, M.G.; Tomasic, G.; Squicciarini, P.; Salvadori, B., 1996:
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

Van Haselen, C.W.; Vermeer, M.H.; Toonstra, J.; Van Der Putte, S.C.J.; Mulder, P.G.H.; Van Vloten, W.A.; Willemze, R., 1997:
P53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas

Kurvinen, K.; Syrjänen, K.; Syrjänen, S., 1996:
p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions

Goh, H.S.; Chan, C.S.en; Khine, K.; Smith, D.R., 1994:
P53 and behaviour of colorectal cancer

Kamel, D.; Pääkkö, P.; Nuorva, K.; Vähäkangas, K.; Soini, Y., 1993:
p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder

Barbareschi, M.; Leonardi, E.; Mauri, F.A.; Serio, G.; Dalla Palma, P., 1992:
p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer

Skopelitou, A.; Hadjiyannakis, M.; Dimopoulos, D.; Kamina, S.; Krikoni, O.; Alexopoulou, V.; Rigas, C.; Agnantis, N.J., 1997:
p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage

Fox, S.B.; Persad, R.A.; Royds, J.; Kore, R.N.; Silcocks, P.B.; Collins, C.C., 1993:
p53 and c-myc expression in stage A1 prostatic adenocarcinoma: useful prognostic determinants?

Pignataro, L.; Capaccio, P.; Pruneri, G.; Carboni, N.; Fracchiolla, N.; Richelda, R.; Scaramellini, G.; Neri, A.; Buffa, R., 1996:
p53 and cyclin D1 protein expression in glottic laryngeal squamous cell carcinomas involving the anterior commissure (pT1bN0M0)

Moch, H.; Sauter, G.; Moore, D.; Mihatsch, M.J.; Gudat, F.; Waldman, F., 1993:
p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer

ter Harmsel, B.; van Belkum, A.; Quint, W.; Pronk, A.; Kuijpers, J.; Ramaekers, F.; Tandon, A.; Smedts, F., 1995:
p53 and human papilloma virus type 16 in cervical intraepithelial neoplasia and carcinoma

Furihata, M.; Yamasaki, I.; Ohtsuki, Y.; Sonobe, H.; Morioka, M.; Yamamoto, A.; Terao, N.; Kuwahara, M.; Fujisaki, N., 1995:
P53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions

Neubauer, A.; Thiede, C.; Huhn, D.; Wittig, B., 1996:
P53 and induction of apoptosis as a target for anticancer therapy

Lee, S.; Elenbaas, B.; Levine, A.; Griffith, J., 1995:
P53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form in insertion/deletion mismatches

Gotz, C.; Montenarh, M., 1995:
P53 and its implication in apoptosis (review)

Gelsleichter, L.; Gown, A.M.; Zarbo, R.J.; Wang, E.; Coltrera, M.D., 1995:
p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors

Kuwano, K.; Hagimoto, N.; Nomoto, Y.; Kawasaki, M.; Kunitake, R.; Fujita, M.; Miyazaki, H.; Hara, N., 1997:
P53 and p21 (Waf1/Cip1) mRNA expression associated with DNA damage and repair in acute immune complex alveolitis in mice

Moskaluk, C.A.; Heitmuller, R.; Zahurak, M.; Schwab, D.; Sidransky, D.; Hamilton, S.R., 1996:
p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction

Griffiths, T.R.L.; Mellon, J.K.; Pyle, G.A.; Shenton, B.K.; Neal, D.E., 1995:
P53 and ploidy assessed by flow cytometry in bladder washings

Smith, D.R.; Goh, H.S., 1996:
p53 and prognosis in colorectal cancer

Tomita, T., 1997:
p53 and proliferating cell nuclear antigen in endocrine tumors of pancreas and intestinal carcinoids

Husgafvel-Prusiainen, K.; Ridanpaa, M.; Anttila, S.; Vainio, H., 1995:
P53 and ras Gene mutations in lung cancer: Implications for smoking and occupational exposures

Long, X.; Boluyt, M.O.; Hipolito, M.L.; Lundberg, M.S.; Zheng, J.S.; O'Neill, L.; Cirielli, C.; Lakatta, E.G.; Crow, M.T., 1997:
p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes

Hirota, Y.; Horiuchi, T.; Akahane, K., 1996:
p53 antisense oligonucleotide inhibits growth of human colon tumor and normal cell lines

Puisieux, A.; Ponchel, F.; Ozturk, M., 1993:
p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells

Geisler, J.P.; Wiemann, M.C.; Zhou, Z.; Miller, G.A.; Geisler, H.E., 1996:
p53 as a prognostic indicator in endometrial cancer

Roth, J.; Dittmer, D.; Rea, D.; Tartaglia, J.; Paoletti, E.; Levine, A., J., 1996:
P53 as a target for cancer vaccines: Recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge

Silvestrinin, R.; Benini, E.; Grazia Daidone, M.; Veneroni, S.; Boracchi, P.; Cappelletti, V.; D.F.onzo, G.; Veronesi, U., 1993:
P53 as an independent prognostic marker in lymph node-negative breast cancer patients

Silva, N.; Costa, M.; Madi, K.; Barbosa, L.; Rosas, S.; Carvalho, M., 1996:
p53 as tumor marker for the early detection of reincidence in lung cancer

Marsigliante, S.; Leo, G.; Mottaghi, A.; Biscozzo, L.; Greco, S.; Storelli, C., 1993:
P53 associated with cathepsin D in primary breast cancer

Hainaut, P., 1997:
P53 at the atomic scale: the multiple faces of a crystal

Friedrich, R.E.; Bartel-Friedrich, S.; Plambeck, K.; Bahlo, M.; Klapdor, R., 1997:
P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma

Bakalkin, G.; Yakovleva, T.; Selivanova, G.; Magnusson, K.P.; Szekely, L.; Kiseleva, E.; Klein, G.; Terenius, L.; Wiman, K.G., 1994:
p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer

Bakalkin, G.; Selivanova, G.; Yakovleva, T.; Kiseleva, E.; Kashuba, E.; Magnusson, K.P.; Szekely, L.; Klein, G.; Terenius, L.; Wiman, K.G., 1995:
p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain

Zhao, J.; Schmieg, F.I.; Logsdon, N.; Freedman, D.; Simmons, D.T.; Molloy, G.R., 1996:
p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription

Hu, L.; Aizawa, S.; Tokuhisa, T., 1995:
p53 controls proliferation of early B lineage cells by a p21 (WAF1/Cip1)-independent pathway

Bellamy, C.O.; Clarke, A.R.; Wyllie, A.H.; Harrison, D.J., 1997:
p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage

Hendry, J.H.; Adeeko, A.; Potten, C.S.; Morris, I.D., 1996:
P53 deficiency produces fewer regenerating spermatogenic tubules after irradiation

Matsuyama, H.; Pan, Y.; Mahdy, E.A.; Malmström, P.U.; Hedrum, A.; Uhlen, M.; Busch, C.; Hirano, T.; Auer, G.; Tribukait, B., 1994:
p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization

Niewolik, D.; Vojtesek, B.; Kovarik, J., 1995:
p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence

Fonseca, L.; Yonemura, Y.; De Aretxabala, X.; Yamaguchi, A.; Miwa, K.; Miyazaki, I., 1994:
p53 detection as a prognostic factor in early gastric cancer

Wang, Y.; Reed, M.; Wang, P.; Stenger, J.E.; Mayr, G.; Anderson, M.E.; Schwedes, J.F.; Tegtmeyer, P., 1993:
p53 domains: identification and characterization of two autonomous DNA-binding regions

Reed, M.; Wang, Y.; Mayr, G.; Anderson, M.E.; Schwedes, J.F.; Tegtmeyer, P., 1993:
p53 domains: suppression, transformation, and transactivation

Scott, N.; Bell, S.M.; Sagar, P.; Blair, G.E.; Dixon, M.F.; Quirke, P., 1993:
p53 expression and K-ras mutation in colorectal adenomas

Nishimura, Y.; Wato, M., 1994:
P53 expression and Ki-67 antigen localization in oral cancer and their correlation with tumor differentiation and invasion

Thomas, D.J.; Robinson, M.; King, P.; Hasan, T.; Charlton, R.; Martin, J.; Carr, T.W.; Neal, D.E., 1993:
P53 expression and clinical outcome in prostate cancer

Stål, O.; Stenmark Askmalm, M.; Wingren, S.; Rutqvist, L.E.; Skoog, L.; Ferraud, L.; Sullivan, S.; Carstensen, J.; Nordenskjöld, B., 1995:
p53 expression and the result of adjuvant therapy of breast cancer

Antoniades, H.N.; Galanopoulos, T.; Neville-Golden, J.; Kiritsy, C.P.; Lynch, S.E., 1994:
p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine

Hughes, J.H.; Robinson, R.A., 1995:
p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin

Garcia, J.F.; Piris, M.A.; Lloret, E.; Orradre, J.L.; Murillo, P.G.; Martienz, J.C., 1997:
P53 expression in CMV-infected cells: Association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2

Matias-Guiu, X.; Cuatrecasas, M.; Musulen, E.; Prat, J., 1994:
p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas

Lopez-Muniz, A.; Trivino, A.; Hernandez, L.; Perez, A.; Bengoechea, E.; Claros, I., 1997:
P53 expression in benign and malign breast lesions. A semiquantitative immunocytochemical study including correlations with morphoprognostic factors

Ciesielski, D.; Dziewulska-Bokiniec, A.; Zółtowska, A.; Roszkiewicz, A.; Kopacz, A.; Wojtacki, J., 1995:
p53 expression in breast cancer related to prognostic factors

Kaklamanis, L.; Gatter, K.C.; Mortensen, N.; Baigrie, R.J.; Heryet, A.; Lane, D.P.; Harris, A.L., 1993:
p53 expression in colorectal adenomas

Lanza, G.; Maestri, I.; Dubini, A.; Gafa, R.; Santini, A.; Ferretti, S.; Cavazzini, L., 1996:
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival

Simms, W.W.; Ordonez, N.G.; Johnston, D.; Ayala, A.G.; Czerniak, B., 1995:
P53 expression in dedifferentiated chondrosarcoma

Ogden, G.R.; Lane, D.P.; Chisholm, D.M., 1993:
p53 expression in dyskeratosis congenita: a marker for oral premalignancy?

Lee, Y.S., 1995:
p53 expression in gestational trophoblastic disease

Wee, A.; Teh, M.; Raju, G.C., 1995:
p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection

Tomasino, R.M.; Morello, V.; Tralongo, V.; Nagar, C.; Nuara, R.; Daniele, E.; Curti, M.; Orestano, F., 1994:
p53 expression in human renal cell carcinoma: an immunohistochemical study and a literature outline of the cytogenetic characterization

Van Veldhuizen, P.J.; Sadasivan, R.; Cherian, R.; Dwyer, T.; Stephens, R.L., 1993:
p53 expression in incidental prostatic cancer

Soini, Y.; Pääkkö, P.; Alavaikko, M.; Vähäkangas, K., 1992:
p53 expression in lymphatic malignancies

Nakanishi, Yukihiro; Noguchi, Masayuki; Matsuno, Yoshihiro; Saikawa, Masahisa; Mukai, Kiyoshi; Shimosato, Yukio; Hirohashi, Setsuo, 1995:
P53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract: Immunohistochemical analysis of 95 lesions

Kitagawa, M.; Yoshida, S.; Kuwata, T.; Tanizawa, T.; Kamiyama, R., 1994:
p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia

Messmer, U.K.; Ankarcrona, M.; Nicotera, P.; Bruene, B., 1994:
P53 expression in nitric oxide-induced apoptosis

Walker, C.; Robertson, L.J.; Myskow, M.W.; Pendleton, N.; Dixon, G.R., 1994:
p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas

Korkolopoulou, P.; Oates, J.; Crocker, J.; Edwards, C., 1993:
p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen

Li, T.J.n; Browne, R.M.; Prime, S.S.; Paterson, I.C.; Matthews, J.B., 1996:
P53 expression in odontogenic keratocyst epithelium

Cheville, J.C.; Robinson, R.A.; Benda, J.A., 1996:
p53 expression in placentas with hydropic change and hydatidiform moles

Lee, Y.S.n; Teh, M., 1994:
P53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin

Pignone, A.; Calzolari, A.; Cerinic, M.M.tucci; Scaletti, C.; Messerini, L.; Lombardi, A.; Generini, S.; Giannelli, E.; Carossino, A.; Baroni, G.; Cagnoni, M., 1994:
P53 expression in the skin of Systemic sclerosis (SSc): An immunohistochemical study of eight cases

Jay, V.; Yi, Q.; Hunter, W.S.; Zielenska, M., 1996:
p53 expression in uveal malignant melanomas

Kafiri, G.; Thomas, D.M.; Shepherd, N.A.; Krausz, T.; Lane, D.P.; Hall, P.A., 1992:
P53 expression is common in malignant mesothelioma

Fresno, M.; Molina, R.; Perez Del Rio, M.J.; Alvarez, S.; Diaz Iglesias, J.M.; Garcia, I.; Herrero, A., 1997:
P53 expression is of independent predictive value in lymph node-negative breast carcinoma

Benveniste, P.; Cohen, A., 1995:
p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency

Brotherick, I.; Shenton, B., K.; Cowan, W., K.; Angus, B.; Horne, C., H.W.; Higgs, M., J.; Lennard, T., W.J., 1995:
P53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer

Yao, T.; Utsunomiya, T.; Nagai, E.; Oya, M.; Tsuneyoshi, M., 1996:
P53 expression patterns in colorectal adenomas and early carcinomas: A special reference to depressed adenoma and non-polypoid carcinoma

Daidone, M.G.; Benini, E.; Valentinis, B.; Tomasic, G.; Bolis, G.; Villa, A.; Silvestrini, R., 1996:
p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumours

Costa, A.; Silvestrini, R.; Mochen, C.; Lequaglie, C.; Boracchi, P.; Faranda, A.; Vessecchia, G.; Ravasi, G., 1996:
P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer

McManus, D.T.; Yap, E.P.; Maxwell, P.; Russell, S.E.; Toner, P.G.; McGee, J.O., 1994:
p53 expression, mutation, and allelic deletion in ovarian cancer

Thomas, D.J.; Robinson, M.C.; Charlton, R.; Wilkinson, S.; Shenton, B.K.; Neal, D.E., 1994:
P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder

Shin, D., M.; Lee, J., S.; Lippman, S., M.; Lee, J.J.ck; Tu, Z.N.ra; Choi, G.; Heyne, K.; Shin, H.-Ju, C.; Ro, J., Y.; Goepfert, H.; Hong, W.-Ki; Hittelman, W., N., 1996:
P53 expression: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma

Wagner, P., 1994:
P53 forms tight complexes with tms1 of fission yeast

Cereseto, A.; Diella, F.; Mulloy, J.C.; Cara, A.; Michieli, P.; Grassmann, R.; Franchini, G.; Klotman, M.E., 1996:
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells

Teramoto, T.; Satonaka, K.; Kitazawa, S.; Fujimori, T.; Hayashi, K.; Maeda, S., 1994:
p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis

Taniguchi, Y., 1995:
p53 gene abnormalities in advanced primary lung cancer and metastatic tumors

Guo, W.; Wang, X.; Feng, C., 1996:
P53 gene abnormalities in osteosarcoma

Kusama, K.; Okutsu, S.; Takeda, A.; Himiya, T.; Kojima, A.; Kidokoro, Y.; Chu, L.; Iwanari, S.; Kudo, I.; Moro, I., 1996:
p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma

Bertorelle, R.; Esposito, G.; Belluco, C.; Bonaldi, L.; Del Mistro, A.; Nitti, D.; Lise, M.; Chieco-Bianchi, L., 1996:
p53 gene alterations and protein accumulation in colorectal cancer

Herrmann, M.; Baunoch, D.; Maliarik, M.; Kost, J.; Linden, M.; Latif, N.; Lalley, P.; Talpos, G.; Kaplan, E.; Thompson, N.; Rydstedt, L.; Moll, U.; Tewari, A.; Lane, M., 1995:
P53 gene alterations in differentiated thyroid cancers

Karameris, A.M.; Worthy, E.; Gorgoulis, V.G.; Quezado, M.; Anastassiades, O.T., 1995:
p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material

Ayter, Sukriye, 1996:
P53 gene and tumor suppression

Ohashi, M.; Hatakeyama, K.; Aizawa, S.; Kominami, R., 1996:
P53 gene deficiency does not enhance instability of mouse minisatellites in somatic cells of normal tissues

Döhner, H.; Fischer, K.; Bentz, M.; Hansen, K.; Benner, A.; Cabot, G.; Diehl, D.; Schlenk, R.; Coy, J.; Stilgenbauer, S., 1995:
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

Jonveaux, P., 1993:
P53 gene in hematological malignancies

Vesey, D.A.; Hayward, N.K.; Cooksley, W.G., 1994:
p53 gene in hepatocellular carcinomas from Australia

Yavorkovskii, L.I.; Yavorkovskii, L.L., 1994:
P53 gene in lymphoproliferative disease

Halevy, O., 1993:
p53 gene is up-regulated during skeletal muscle cell differentiation

Jaskiewicz, K.; De Groot, K.M., 1994:
p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium

Ninomiya, Y.; Urano, Y.; Yoshimoto, K.; Iwahana, H.; Sasaki, S.; Arase, S.; Itakura, M., 1997:
P53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma

Hollstein, M.; Bartsch, H.; Wesch, H.; Kure, E.H.; Mustonen, R.; Mühlbauer, K.R.; Spiethoff, A.; Wegener, K.; Wiethege, T.; Müller, K.M., 1997:
p53 gene mutation analysis in tumors of patients exposed to alpha-particles

Sparrow, L.E.; Soong, R.; Dawkins, H.J.; Iacopetta, B.J.; Heenan, P.J., 1995:
p53 gene mutation and expression in naevi and melanomas

Hsu, I.C.; Tokiwa, T.; Bennett, W.; Metcalf, R.A.; Welsh, J.A.; Sun, T.; Harris, C.C., 1993:
P53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines

Min, H.; Kudo, E.; Hino, A.; Yoshimoto, K.; Iwahana, H.; Itakura, M.; Izumi, K., 1997:
P53 gene mutation in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder tumors and N-methyl-N-nitrosourea-induced colon tumors of rats

Ho, Y.S.n; Hsieh, L.L.ng; Chen, J.S.i; Chang, C.N.n; Lee, S.T.eng; Chiu, L.L.ng; Chin, T.Y.; Cheng, S.C.u, 1996:
P53 gene mutation in cerebral primitive neuroectodermal tumor in Taiwan

Theillet, C., 1993:
P53 gene mutation in human solid tumors

Yoshimura, I.; Kudoh, J.; Saito, S.; Tazaki, H.; Shimizu, N., 1995:
P53 gene mutation in recurrent superficial bladder cancer

Nayak, B.K.; Baral, R.N.; Das, B.R., 1996:
p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer

Ho, Y.S.n; Tseng, S.C.u; Chin, T.Y.; Hsieh, L.L.ng; Lin, J.D.r, 1996:
P53 gene mutation in thyroid carcinoma

Ichikawa, D.; Yamaguchi, T.; Shirasu, M.; Kitamura, K.; Inazawa, J.; Abe, T.; Takahashi, T., 1996:
p53 gene mutation is not directly related to tumoricidal effects of preoperative radiochemohyperthermia therapy for rectal cancers

Ng, I.O.; Chung, L.P.; Tsang, S.W.; Lam, C.L.; Lai, E.C.; Fan, S.T.; Ng, M., 1994:
p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese

Bar-Eli, M.; Abbruzzese, J.L.; Lee-Jackson, D.; Frost, P., 1993:
p53 gene mutation spectrum in human unknown primary tumors

Ho, Yuan Soon; Cheng, Hui Teng; Wang, Ying Jan; Lin, Jen Kun, 1995:
P53 gene mutational spectra in hepatocellular carcinomas induced by 2-acetylaminofluorene and N-nitroso-2-acetylaminofluorene in rats

Riethdorf, S.; Friedrich, R., E.; Ostwald, C.; Barten, M.; Gogacz, P.; Gundlach, K., K.H.; Schlechte, H.; Becker, J.; Bregenzer, T.; Riethdorf, L.; Loening, T., 1997:
P53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: A long term follow-up study

Günther, T.; Schneider-Stock, R.; Rys, J.; Niezabitowski, A.; Roessner, A., 1997:
p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors

Nakai, H.; Misawa, S.; Tanaka, S.; Nishigaki, H.; Taniwaki, M.; Yokota, S.; Horiike, S.; Takashima, T.; Seriu, T.; Nakagawa, H., 1993:
p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia

Kupryjańczyk, J.; Thor, A.D.; Beauchamp, R.; Merritt, V.; Edgerton, S.M.; Bell, D.A.; Yandell, D.W., 1993:
p53 gene mutations and protein accumulation in human ovarian cancer

Caleffi, M.; Teague, M.W.; Jensen, R.A.; Vnencak Jones, C.L.; Dupont, W.D.; Parl, F.F., 1994:
P53 gene mutations and steroid receptor status in breast cancer

Fan, S.; el-Deiry, W.S.; Bae, I.; Freeman, J.; Jondle, D.; Bhatia, K.; Fornace, A.J.; Magrath, I.; Kohn, K.W.; O'Connor, P.M., 1994 :
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents

Tashiro, H.; Isacson, C.; Levine, R.; Kurman, R.J.; Cho, K.R.; Hedrick, L., 1997:
p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis

Ollikainen, H.; Syrjänen, S.; Koskela, K.; Pelliniemi, T.T.; Pulkki, K., 1997:
p53 gene mutations are rare in patients but common in patient-originating cell lines in multiple myeloma

Chen, G.; He, K.; Xu, L., 1995:
P53 gene mutations in 48 cases of non-Hodgkin's lymphomas

Ye, D.W.; Zheng, J.; Qian, S.X.; Ma, Y.; Zheng, X.; Li, D.; Gu, S., 1993:
p53 gene mutations in Chinese human testicular seminoma

Hsieh, L.L.ng; Hsia, C.F.ng; Wang, L.Y.; Chen, C.J.n; Ho, Y.S.n, 1994:
P53 gene mutations in brain tumors in Taiwan

Saitoh, S.; Cunningham, J.; D.V.ies, E.M.; McGovern, R.M.; Schroeder, J.J.; Hartmann, A.; Blaszyk, H.; Wold, L.E.; Schaid, D.; Sommer, S.S., 1994:
p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis

Tohdo, H.; Yokazaki, H.; Haruma, K.; Kajiyama, G.; Tahara, E., 1993:
P53 gene mutations in gastric adenomas

Molès, J.P.; Moyret, C.; Guillot, B.; Jeanteur, P.; Guilhou, J.J.; Theillet, C.; Basset-Sèguin, N., 1993:
p53 gene mutations in human epithelial skin cancers

Owen, R.G.; Davis, S.A.; Randerson, J.; Rawstron, A.C.; Davies, F.; Child, J.A.; Jack, A.S.; Morgan, G.J., 1997:
p53 gene mutations in multiple myeloma

Neri, A.; Baldini, L.; Trecca, D.; Cro, L.; Polli, E.; Maiolo, A.T., 1993:
p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy

Kanekura, T.; Kanzaki, T.; Kanekura, S.; Kawahara, K.; Nakashima, T.; Kitajima, I.; Maruyama, I., 1995:
P53 gene mutations in skin cancers with underlying disorders

Schneider Stock, R.; Radig, K.; Oda, Y.; Mellin, W.; Rys, J.; Niezabitowski, A.; Roessner, A., 1997:
P53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy

Seth, A.; Palli, D.; Mariano, J.M.; Metcalf, R.; Venanzoni, M.C.; Bianchi, S.; Kottaridis, S.D.; Papas, T.S., 1994:
P53 gene mutations in women with breast cancer and a previous history of benign breast disease

Hartmann, A.; Blaszyk, H.; McGovern, R.M.; Schroeder, J.J.; Cunningham, J.; D.V.ies, E.M.; Kovach, J.S.; Sommer, S.S., 1995:
p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers

Sen, S.; Zhou, H.; Andersson, B.S.; Cork, A.; Freireich, E.J.; Stass, S.A., 1995:
p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro

Ohshima, S.; Xu, Y., 1997:
p53 gene mutations, and CYP1A1 and GSTM1 genotypes in pulmonary squamous cell carcinomas

Sjalander, A.; Birgander, R.; Athlin, L.; Stenling, R.; Rutegard, J.; Beckman, L.; Beckman, G., 1995:
P53 germ line haplotypes associated with increased risk for colorectal cancer

Tsuchiya, A.; Abe, R.; Kanno, M.; Anzai, K., 1997:
p53 immunohistochemical analysis of the lymph nodes in node-negative breast cancer patients who had subsequent relapse

Soino, Y.; Niemela, A.; Kamel, D.; Herva, R.; Bloigu, R.; Paakko, P.; Vahakangas, K., 1994:
P53 immunohistochemical positivity as a prognostic marker in intracranial tumours

Lombardi, T.; Odell, E.W.; Morgan, P.R., 1995:
P53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal-cell budding and basal-cell naevus syndrome

Hirota, S.; Kudo, S.; Hosobe, S.; Kobayashi, T.; Himori, M.; Ikeda, M.; Takemoto, Y.; Nomoto, M.; Aoyagi, Y.; Asakura, H., 1995:
p53 immunoreactive stain and early colorectal adenocarcinomas

al-Sarraj, S.; Bridges, L.R., 1995:
p53 immunoreactivity in astrocytomas and its relationship to survival

Jeffers, M.D.; Richmond, J.; Farquharson, M.; McNicol, A.M., 1994:
p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium

Proby, C.M.; Menage, H.D.P.loux; Mcgregor, J.M.; Hobbs, C.; Norris, P.G.; Smith, N.; Hawak, J.L.M.; Mckee, P.H., 1993:
P53 immunoreactivity in cutaneous PUVA tumor is similar to that in other non-melanoma skin neoplasms

Mcgregor, J.M.; Yu, C.C.W.; Dublin, E.A.; Barnes, D.M.; Levison, D.A.; Macdonald, D.M., 1993:
P53 immunoreactivity in human malignant melanoma and dysplastic naevi

Khorshid, S.M.; Glover, M.T.; Churchill, L.; Mcgregor, J.M.; Proby, C.M., 1996:
P53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: A comparative study of 246 tumours

Tiniakos, D.G.; Healicon, R.M.; Hair, T.; Wadehra, V.; Horne, C.H.; Angus, B., 1995 :
p53 immunostaining as a marker of malignancy in cytologic preparations of body fluids

Higashiyama, M.; Doi, O.; Yokouchi, H.; Kodama, K.; Tateishi, R., 1995:
P53 immunostaining in combined type small cell lung cancer

Esposito, V.; Baldi, A.; De Luca, A.; Claudio, P.P.; Signoriello, G.; Bolognese, A.; Centonze, P.; Giordano, G.G.; Caputi, M.; Baldi, F.; Giordano, A., 1997:
p53 immunostaining in differential diagnosis of pleural mesothelial proliferations

Mayall, F.; Rutty, K.; Campbell, F.; Goddard, H., 1994:
P53 immunostaining suggests that uterine carcinosarcomas are monoclonal

Matias-Guiu, X.; Villanueva, A.; Cuatrecasas, M.; Capella, G.; De Leiva, A.; Prat, J., 1996:
p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma

Bi, S.; Hughes, T.; Bungey, J.; Chase, A.; de Fabritiis, P.; Goldman, J.M., 1992:
p53 in chronic myeloid leukemia cell lines

Molinari, M.; Milner, J., 1995:
p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6

Sherman, M., E.; Bur, M., E.; Kurman, R., J., 1995:
P53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis

Imamura, J.; Miyoshi, I.; Koeffler, H.P., 1994:
p53 in hematologic malignancies

Schaff, Z.; Sarosi, I.; Hsia, C.C.; Kiss, A.; Tabor, E., 1995:
p53 in malignant and benign liver lesions

Rosen, P.P.; Lesser, M.L.; Arroyo, C.D.; Cranor, M.; Borgen, P.; Norton, L., 1995:
p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

Chi, S.G.; deVere White, R.W.; Meyers, F.J.; Siders, D.B.; Lee, F.; Gumerlock, P.H., 1994:
p53 in prostate cancer: frequent expressed transition mutations

Boers, J., E.; Ten-Velde, G., P.M.; Thunnissen, F., B.J.M., 1996:
P53 in squamous metaplasia: A marker for risk of respiratory tract carcinoma

Havre, P.A.; Yuan, J.; Hedrick, L.; Cho, K.R.; Glazer, P.M., 1995:
p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells

Pierzchalski, P.; Reiss, K.; Cheng, W.; Cirielli, C.; Kajstura, J.; Nitahara, J.A.; Rizk, M.; Capogrossi, M.C.; Anversa, P., 1997:
p53 Induces myocyte apoptosis via the activation of the renin-angiotensin system

Sakhi, S.; Bruce, A.; Sun, N.; Tocco, G.; Baudry, M.; Schreiber, S.S., 1994:
p53 induction is associated with neuronal damage in the central nervous system

Gurley, K.E.; Kemp, C.J., 1996:
p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice

Staib, C.; Pesch, J.; Gerwig, R.; Gerber, J.K.; Brehm, U.; Stangl, A.; Grummt, F., 1996:
p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen

Chesnokov, I.; Chu, W.M.; Botchan, M.R.; Schmid, C.W., 1996:
p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner

Janicek, M.F.; Angioli, R.; Unal, A.D.; Sevin, B.U.; Madrigal, M.; Estape, R.; Averette, H.E., 1997:
p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines

Mukhopadhyay, T.; Roth, J.A., 1996:
p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines

Guillouf, C.; Rosselli, F.; Krishnaraju, K.; Moustacchi, E.; Hoffman, B.; Liebermann, D.A., 1995:
p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis

Enokido, Y.; Araki, T.; Aizawa, S.; Hatanaka, H., 1996:
P53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons

Lin, D.L.; Chang, C., 1996:
p53 is a mediator for radiation-repressed human TR2 orphan receptor expression in MCF-7 cells, a new pathway from tumor suppressor to member of the steroid receptor superfamily

Roehlke, P.; Milde-Langosch, K.; Weyland, C.; Pichlmeier, U.; Jonat, W.; Loening, T., 1997:
P53 is a persistent and predictive marker in advanced ovarian carcinomas: Multivariate analysis including comparison with Ki67 immunoreactivity

Yin, Y.; DeWolf, W.C.; Morgentaler, A., 1997:
p53 is associated with the nuclear envelope in mouse testis

Fontoura, B.M.; Sorokina, E.A.; David, E.; Carroll, R.B., 1992:
p53 is covalently linked to 5.8S rRNA

Ying, S.; Zhang, Z.; Batres, Y.; Zhao, Y.; Lin, S.; Li, G., 1997:
p53 is involved in the inhibition of cell proliferation mediated by activin A in cultured human prostate cancer LNCaP cells

Bookstein, R.; MacGrogan, D.; Hilsenbeck, S.G.; Sharkey, F.; Allred, D.C., 1993:
p53 is mutated in a subset of advanced-stage prostate cancers

D.B.nedetti, V.M.; Welsh, J.A.; Trivers, G.E.; Harpster, A.; Parkinson, A.J.; Lanier, A.P.; McMahon, B.J.; Bennett, W.P., 1995:
p53 is not mutated in hepatocellular carcinomas from Alaska Natives

Silva, A.; Wyllie, A.; Collins, M.K., 1997:
p53 is not required for regulation of apoptosis or radioprotection by interleukin-3

Bogue, M.A.; Zhu, C.; Aguilar-Cordova, E.; Donehower, L.A.; Roth, D.B., 1996:
p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes

Lowe, S.W.; Schmitt, E.M.; Smith, S.W.; Osborne, B.A.; Jacks, T., 1993:
P53 is required for radiation induced apoptosis in mouse thymocytes

Chen, X.; Ko, L.J.; Jayaraman, L.; Prives, C., 1996:
p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

Stuppia, L.; Calabrese, G.; Peila, R.; Guanciali Franchi, P.; Morizio, E.; Spadano, A.; Palka, G., 1997:
P53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis

Moll, U., M.; Ostermeyer, A., G.; Ahomadegbe, J.-Charles; Mathieu, M.-Christine; Riou, G., 1995:
p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies

Linke, S.P.; Clarkin, K.C.; Wahl, G.M., 1997:
p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation

Kovar, H.; Auinger, A.; Jug, G.; Müller, T.; Pillwein, K., 1992:
p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree

Runnebaum, I.B.; Tong, X.W.; Moebus, V.J.; Kieback, D.G.; Rosenthal, H.E.; Kreienberg, R., 1994:
P53 mutant His-175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6

Schmieg, F.I.; Simmons, D.T., 1993:
p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells

Ikenberg, H.; Matthay, K.; Schmitt, B.; Bauknecht, T.; Kiechle Schwarz, M.; Goeppinger, A.; Pfleiderer, A., 1995:
P53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas

Leach, F.S.; Tokino, T.; Meltzer, P.; Burrell, M.; Oliner, J.D.; Smith, S.; Hill, D.E.; Sidransky, D.; Kinzler, K.W.; Vogelstein, B., 1993:
p53 Mutation and MDM2 amplification in human soft tissue sarcomas

Kroumpouzos, G.; Eberle, J.; Garbe, C.; Orfanos, C.E., 1994:
P53 mutation and c-fos overexpression are associated with detection of the antigen VLA-2 in human melanoma cell lines

Kim, G.; Yamabe, H.; Imadashirakata, Y.; Ueda, S.; Sakai, M.; Okuma, M.; Ishizaki, K., 1997:
p53 mutation and protein overexpression in the early stages of esophageal tumorigenesis utilizing endoscopically obtained biopsy specimens

Bradford, C.R.; Zhu, S.; Poore, J.; Fisher, S.G.; Beals, T.F.; Thoraval, D.; Hanash, S.M.; Carey, T.E.; Wolf, G.T., 1997:
P53 mutation as a prognostic marker in advanced laryngeal carcinoma

Taylor, J.A.; Watson, M.A.; Devereux, T.R.; Michels, R.Y.; Saccomanno, G.; Anderson, M., 1994:
P53 mutation hotspot in radon-associated lung cancer

Akasaka, T.; Muramatsu, M.; Kadowaki, N.; Ohno, H.; Ishizaki, K.; Yamabe, H.; Fukuhara, S.; Okuma, M., 1996:
p53 mutation in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with chromosomal translocations

Sheridan, E.; Silcocks, P.; Smith, J.; Hancock, B.W.; Goyns, M.H., 1994:
P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance

Yeargin, J.; Cheng, J.; Yu, A.L.; Gjerset, R.; Bogart, M.; Haas, M., 1993:
P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines

Lee, J.H.; Kang, Y.S.on; Park, S.Y.on; Kim, B.G.e; Lee, E.D.n; Lee, K.H.e; Park, K.B.ck; Kavanagh, J.J.; Wharton, J.T., 1995:
P53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor

Shiraishi, Yukimasa, 1993:
P53 mutation in fresh lymphocytes, B-lymphoblastoid cell lines and their transformed cell lines originating from Bloom syndrome patients

Lo, K.W.; Mok, C.H.; Huang, D.P.; Liu, Y.X.; Choi, P.H.; Lee, J.C.; Tsao, S.W., 1992:
p53 mutation in human nasopharyngeal carcinomas

Adamson, D.J.; Dawson, A.A.; Bennett, B.; King, D.J.; Haites, N.E., 1995:
p53 mutation in the myelodysplastic syndromes

Milner, B.J.; Allan, L.A.; Eccles, D.M.; Kitchener, H.C.; Leonard, R.C.; Kelly, K.F.; Parkin, D.E.; Haites, N.E., 1993:
p53 mutation is a common genetic event in ovarian carcinoma

Sander, C.A.; Yano, T.; Clark, H.M.; Harris, C.; Longo, D.L.; Jaffe, E.S.; Raffeld, M., 1993:
p53 mutation is associated with progression in follicular lymphomas

Asamoto, M.; Mann, A.M.; Cohen, S.M., 1994:
p53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo

Takata, M.; Rehman, I.; Rees, J., L., 1997:
P53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light

McManus, D.T.; Murphy, M.; Arthur, K.; Hamilton, P.W.; Russell, S.E.; Toner, P.G., 1996:
p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma

van Meyel, D.J.; Ramsay, D.A.; Casson, A.G.; Keeney, M.; Chambers, A.F.; Cairncross, J.G., 1994:
p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression

Lung, M.L.; Chan, W.C.; Zong, Y.S.; Tang, C.M.; Fok, C.L.; Wong, K.T.; Chan, L.K.; Lau, K.W., 1996:
p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China

Tsuda, H.; Iwaya, K.; Fukutomi, T.; Hirohashi, S., 1993:
p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade

D'Errico, M.; Calcagnile, A.S.; Corona, R.; Fucci, M.; Annessi, G.; Baliva, G.; Tosti, M.E.; Pasquini, P.; Dogliotti, E., 1997:
p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age

Marchetti, A.; Buttitta, F.; Pellegrini, S.; Campani, D.; Diella, F.; Cecchetti, D.; Callahan, R.; Bistocchi, M., 1993:
p53 mutations and histological type of invasive breast carcinoma

Massenkeil, G.; Oberhuber, H.; Hailemariam, S.; Sulser, T.; Diener, P.A.; Bannwart, F.; Schäfer, R.; Schwarte-Waldhoff, I., 1994 :
P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer

Tenan, M.; Colombo, B.M.; Pollo, B.; Cajola, L.; Broggi, G.; Finocchiaro, G., 1994:
P53 mutations and microsatellite analysis of loss of heterozygosity in malignant gliomas

Strickler, J.G.; Zheng, J.; Shu, Q.; Burgart, L.J.; Alberts, S.R.; Shibata, D., 1994:
p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail

Uchida, T.; Wada, C.; Ishida, H.; Wang, C.; Egawa, S.; Yokoyama, E.; Kameya, T.; Koshiba, K., 1995:
P53 mutations and prognosis in bladder tumors

Campbell, C.; Quinn, A.G.; Ro, Y.S.ck; Angus, B.; Rees, J.L., 1993:
P53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin

Lasky, T.; Silbergeld, E., 1996:
P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers

Servomaa, K.; Kiuru, A.; Grenman, R.; Pekkola Heino, K.; Pulkkinen, J.O.; Rytomaa, T., 1996:
P53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines

Safran, H.; King, T.; Choy, H.; Gollerkeri, A.; Kwakwa, H.; Lopez, F.; Cole, B.; Myers, J.; Tarpey, J.; Rosmarin, A., 1996:
p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma

Mcgregor, J.M.; Berkhout, R.J.M.; Rozycka, M.; Ter Schegget, J.; Bouwes Bavinck, J.N.; Brooks, L.; Crook, T., 1997:
P53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status

Park, D.J.; Wilczynski, S.P.; Paquette, R.L.; Miller, C.W.; Koeffler, H.P., 1994:
p53 mutations in HPV-negative cervical carcinoma

Chen, W.G.; Chen, Y.Y.; Kamel, O.W.; Koo, C.H.; Weiss, L.M., 1996:
p53 mutations in Hodgkin's disease

Makino, H.; Ushijima, T.; Onda, M.; Nagao, M., 1997:
p53 mutations in MeIQ-induced mouse forestomach tumors

Duthu, A.; Debuire, B.; Romano, J.; Ehrhart, J.C.; Fiscella, M.; May, E.; Appella, E.; May, P., 1992:
p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas

Reincke, M.; Wachenfeld, C.; Mora, P.; Thumser, A.; Jaursch-Hancke, C.; Abdelhamid, S.; Chrousos, G.P.; Allolio, B., 1996:
p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan

Taylor, J.A.; Li, Y.; He, M.; Mason, T.; Mettlin, C.; Vogler, W.J.; Maygarden, S.; Liu, E., 1996:
p53 mutations in bladder tumors from arylamine-exposed workers

Busby-Earle, R.M.; Steel, C.M.; Williams, A.R.; Cohen, B.; Bird, C.C., 1994:
p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status

Van Den Broek, M.H.; Jhanwar, S.C.; Fodde, R.; Chaganti, R.S.K.; Khan, P.M.era, 1993:
P53 mutations in colorectal cancer in the patients of Metropolitan New York

Yamamura Idei, Yuka; Satonaka, Kazuhiro; Fujimori, Takahiro; Maeda, Sakan; Chiba, Tsutou, 1994:
P53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis

Hsieh, L.L.ng; Hsieh, J.T.ung; Wang, L.Y.; Fang, C.Y.u; Chang, S.H.ng; Chen, T.C.ing, 1996 :
P53 mutations in gastric cancers from Taiwan

D.B.nedetti, V.M.; Welsh, J.A.; Yu, M.C.; Bennett, W.P., 1996:
p53 mutations in hepatocellular carcinoma related to oral contraceptive use

Reincke, M.; Karl, M.; Travis, W.H.; Mastorakos, G.; Allolio, B.; Linehan, H.M.; Chrousos, G.P., 1994:
p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies

Cordon-Cardo, C.; Dalbagni, G.; Saez, G., T.; Oliva, M., R.; Zhang, Z.-Feng; Rosai, J.; Reuter, V., E.; Pellicer, A., 1994:
P53 mutations in human bladder cancer: Genotypic versus phenotypic patterns

Miller, C.; Koeffler, H.P., 1993:
P53 mutations in human cancer

Zhang, L.F.; Hemminki, K.; Szyfter, K.; Szyfter, W.; Söderkvist, P., 1994:
p53 mutations in larynx cancer

De Benedetti, V.M.; Travis, L.B.; Welsh, J.A.; van Leeuwen, F.E.; Stovall, M.; Clarke, E.A.; Boice, J.D.; Bennett, W.P., 1996:
p53 mutations in lung cancer following radiation therapy for Hodgkin's disease

Takeshima, Y.; Inai, K.; Bennett, W.P.; Metcalf, R.A.; Welsh, J.A.; Yonehara, S.; Hayashi, Y.; Fujihara, M.; Yamakido, M.; Akiyama, M., 1994:
p53 mutations in lung cancers from Japanese mustard gas workers

Takeshima, Yukio; Seyama, Toshio; Bennett, William, P.; Akiyama, Mitoshi; Tokuoka, Shoji; Inai, Kouki; Mabuchi, Kiyohiko; Land, Charles, E.; Harris, Curtis, C., 1993:
P53 mutations in lung cancers from non-smoking atomic-bomb survivors

Kure, E.H.; Ryberg, D.; Hewer, A.; Phillips, D.H.; Skaug, V.; Baera, R.; Haugen, A., 1996:
p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels

Van Leeuwen, I.S.; Hellmèn, E.; Cornelisse, C.J.; Van den Burgh, B.; Rutteman, G.R., 1996:
P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog

Peller, S.; Halevy, A.; Slutzki, S.; Kopilvo, Y.; Rotter, V., 1995:
P53 mutations in matched primary and metastatic human tumors

Goto, K.; Konomoto, T.; Hayashi, K.; Kinukawa, N.; Naito, S.; Kumazawa, J.; Tsuneyoshi, M., 1997:
p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas

Lung, M.L.; Wong, M.P.; Skaanild, M.T.; Fok, C.L.; Lam, W.K.t; Yew, W.W.i, 1996:
P53 mutations in non-small cell lung carcinomas in Hong Kong

Redston, M.S.; Caldas, C.; Seymour, A.B.; Hruban, R.H.; da Costa, L.; Yeo, C.J.; Kern, S.E., 1994:
p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions

Petersen, I.; Ohgaki, H.; Ludeke, B.I.; Kleihues, P., 1993:
p53 mutations in phenacetin-associated human urothelial carcinomas

Reichel, M.B.; Petersen, H.V.O.gakier; Kleihues, P., 1994:
P53 mutations in primary human lung tumors and their metastases

Park, W.S.ng; Lee, H.K.ung; Lee, J.Y.ung; Yoo, N.J.n; Kim, C.S.ung; Kim, S.H., 1996:
p53 mutations in solar keratoses

Ohgaki, H.; Kleihues, P.; Heitz, P.U., 1993:
P53 mutations in sporadic adrenocortical tumors

Ochiai, A.; Yamauchi, Y.; Hirohashi, S., 1996:
p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia

Masui, T.; Dong, Y.; Yamamoto, S.; Takada, N.; Nakanishi, H.; Inada, K.-Ichi; Fukushima, S.; Tatematsu, M., 1996:
P53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine

Kaino, M.; Kondoh, S.; Okita, S.; Ryozawa, S.; Hatano, S.; Shiraishi, K.; Kaino, S.; Akiyama, T.; Okita, K.; Kawano, T., 1996:
p53 mutations in two patients with intraductal papillary adenoma of the pancreas

Lee, J.M.; Bernstein, A., 1993:
p53 mutations increase resistance to ionizing radiation

Oyama, T.; Kawamoto, T.; Mizoue, T.; Nishida, K.; Osaki, T.; Sugio, K.; Yasumoto, K.; Mitsudomi, T., 1997:
p53 mutations of lung cancer are not significantly affected by CYP1A1 or GSTM1 polymorphisms

Jacquemin Sablon, Alain, 1997:
P53 mutations, asset or liability for cancer chemotherapy?

Buttitta, F.; Marchetti, A.; Athanassiadou, S.; Gadducci, A.; Bellina, S.; Cosio, S.; Mancini, F.; Genazzani, A.; Bevilacqua, G., 1997:
p53 nuclear accumulation in preneoplastic lesions and stage I uterine endometrioid adenocarcinoma

Zeng, Z.S.; Sarkis, A.S.; Zhang, Z.F.; Klimstra, D.S.; Charytonowicz, E.; Guillem, J.G.; Cordon-Cardo, C.; Cohen, A.M., 1994:
p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients

Belluco, C.; Guillem, J.G.; Kemeny, N.; Huang, Y.; Klimstra, D.; Berger, M.F.; Cohen, A.M., 1996:
p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases

Stenger, J.E.; Tegtmeyer, P.; Mayr, G.A.; Reed, M.; Wang, Y.; Wang, P.; Hough, P.V.; Mastrangelo, I.A., 1994:
p53 oligomerization and DNA looping are linked with transcriptional activation

Voeller, H.J.; Sugars, L.Y.; Pretlow, T.; Gelmann, E.P., 1994:
p53 oncogene mutations in human prostate cancer specimens

Carroll, A.G.; Voeller, H.J.mes; Sugars, L.; Gelmann, E.P., 1993:
P53 oncogene mutations in three human prostate cancer cell lines

Zhu, Q.R.; White, F.H.; Tipoe, G.L., 1997:
p53 oncoprotein accumulation in adenoid cystic carcinoma of parotid and palatine salivary glands

Perez, M.I.; Robins, P.; Biria, S.; Roco, J.; Siegel, E.; Pellicer, A., 1997:
P53 oncoprotein expression and gene mutations in some keratoacanthomas

Janssen, K.; Kuntze, J.; Busse, H.; Schmid, K.W., 1996:
p53 oncoprotein overexpression in choroidal melanoma

Niedobitek, G.; Agathanggelou, A.; Barber, P.; Smallman, L.A.; Jones, E.L.; Young, L.S., 1993:
P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas

Zheng, W.; Cao, P.; Zheng, M.; Kramer, E.E.; Godwin, T.A., 1996:
p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes

Rodriguez, R.; Vidart, J.A.; Cristobal, I.; Maestro, M.L.; Lopez, J.; Herraiz, M.A.; Pelayo, A.; Furio, V.; Ortega, M.D.; Coronado, P.J.; Escudero, M., 1997:
P53 overexpression and epithelial ovarian carcinoma

Tenti, P.; Zappatore, R.; Romagnoli, S.; Civardi, E.; Giunta, P.; Scelsi, R.; Stella, G.; Carnevali, L., 1996:
p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters

Kuczyk, M.A.; Bokemeyer, C.; Serth, J.; Hervatin, C.; Oelke, M.; Hoefner, K.; Tan, H.K.; Jonas, U., 1995:
p53 overexpression as a prognostic factor for advanced stage bladder cancer

Bartik, Z.; Nordenskjold, B.; Sun, X., 1997:
p53 overexpression as a prognostic factor in patients with Dukes B colorectal adenocarcinoma

Pich, A.; Chiusa, L.; Margaria, E.; Pia, F.; Navone, R., 1995:
P53 overexpression correlates with proliferative activity and prognosis in carcinomas of the pyriform sinus

Mangham, D.C.; Cannon, A.; Li, X.Q.; Komiya, S.; Gebhardt, M.C.; Springfield, D.S.; Rosenberg, A.E.; Mankin, H.J., 1995:
p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon event

Kohler, M.F.; Carney, P.; Dodge, R.; Soper, J.T.; Clarke Pearson, D.L.; Marks, J.R.; Berchuck, A., 1996:
P53 overexpression in advanced-stage endometrial adenocarcinoma

Rubio, C.A.; Rodensjo, M., 1995:
P53 overexpression in flat serrated adenomas and flat tubular adenomas of the colorectal mucosa

Awwad, S.; Jaros, E.; Soames, J.; Lunec, J., 1996:
P53 overexpression in head and neck carcinoma and radiotherapy results

Munckwikland, E.; Blegen, H.; Lewensohnfuchs, I.; Malec, M.; Auer, G.; Kuylenstierna, R.; Dalianis, T.; Wiman, K.; Lindholm, J., 1997:
p53 overexpression in normal and dysplastic tissues adjacent to p53 negative squamous cell carcinomas of the head and neck

Volkmann, M.; Hofmann, W.J.; Müller, M.; Räth, U.; Otto, G.; Zentgraf, H.; Galle, P.R., 1994:
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation

Eltabbakh, G.H.; Belinson, J.L.; Kennedy, A.W.; Biscotti, C.V.; Casey, G.; Tubbs, R.R.; Blumenson, L.E., 1997:
P53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer

Fuchs, B.; O'Connor, D.; Fallis, L.; Scheidtmann, K.H.; Lu, X., 1995:
p53 phosphorylation mutants retain transcription activity

Milczarek, G.J.; Martinez, J.; Bowden, G.T., 1997:
p53 Phosphorylation: biochemical and functional consequences

Eizenberg, O.; Faber-Elman, A.; Gottlieb, E.; Oren, M.; Rotter, V.; Schwartz, M., 1996:
p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells

Goh, H.S.; Yao, J.; Smith, D.R., 1995:
p53 point mutation and survival in colorectal cancer patients

Yokozaki, H.; Kuniyasu, H.; Kitadai, Y.; Nishimura, K.; Todo, H.; Ayhan, A.; Yasui, W.; Ito, H.; Tahara, E., 1992:
P53 point mutations in primary human gastric carcinomas

Själander, A.; Birgander, R.; Hallmans, G.; Cajander, S.; Lenner, P.; Athlin, L.; Beckman, G.; Beckman, L., 1996:
p53 polymorphisms and haplotypes in breast cancer

Själander, A.; Birgander, R.; Kivelä, A.; Beckman, G., 1995:
p53 polymorphisms and haplotypes in different ethnic groups

Birgander, R.; Sjalander, A.; Rannug, A.; Alexandrie, A.K.; Sundberg, M.I.gelman; Seidegard, J.; Tornling, G.; Beckman, G.; Beckman, L., 1995:
P53 polymorphisms and haplotypes in lung cancer

Birgander, R.; Själander, A.; Zhou, Z.; Fan, C.; Beckman, L.; Beckman, G., 1996:
p53 polymorphisms and haplotypes in nasopharyngeal cancer

Själander, A.; Birgander, R.; Saha, N.; Beckman, L.; Beckman, G., 1996:
p53 polymorphisms and haplotypes show distinct differences between major ethnic groups

Navone, N.M.; Troncoso, P.; Pisters, L.L.; Goodrow, T.L.; Palmer, J.L.; Nichols, W.W.; Von Eschenbach, A.C.; Conti, C.J., 1993:
P53 protein accumulation and gene mutation in the progression of human prostate carcinoma

Wang, L.D.ng; Zhou, Q.; Hong, J.Y.n; Qiu, S.L.ang; Yang, C.S., 1996:
P53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China

Wu, Y.; Hsiu, J.; Lou, Y.; Xia, Z.; Somers, K., 1997:
p53 protein accumulation and genetic alterations in human giant cell tumors of bone (osteoclastomas)

Shipman, R.; Schraml, P.; Moch, H.; Colombi, M.; Sauter, G.; Mihatsch, M.; Ludwig, C., 1997:
p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer

Coggi, G.; Bosari, S.; Roncalli, M.; Graziani, D.; Bossi, P.; Viale, G.; Buffa, R.; Ferrero, S.; Piazza, M.; Blandamura, S.; Segalin, A.; Bonavina, L.; Peracchia, A., 1997:
P53 protein accumulation and p53 gene mutation in esophageal carcinoma: A molecular and immunohistochemical study with clinicopathologic correlations

Nuorva, K.; Soini, Y.; Kamel, D.; Pollanen, R.; Bloigu, R.; Vahakangas, K.; Paakko, P., 1995:
P53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis

Volant, A.; Nousbaum, J.B.; Giroux, M.A.; Roué-Quintin, I.; Metges, J.P.; Férec, C.; Gouérou, H.; Robaszkiewicz, M., 1995:
p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions

Slootweg, Pieter, J., 1995:
P53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study

Mattern, J.; Sauerbrey, A.; Volm, M., 1995:
p53 protein detected by two different antibodies: relationship to proliferation and prognosis in acute lymphoblastic leukemia

Zhou, J.; Cao, S.; Zhang, F.; Huang, K., 1998:
P53 protein expression and DNA content in the cancer cell

Waggoner, S.E.; Anderson, S.M.; Luce, M.C.; Takahashi, H.; Boyd, J., 1996:
p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix

Mothersill, C.; O'Malley, K.; Colucci, S.; Murphy, D.; Lynch, T.; Payne, S.; Seymour, C.; Harney, J., 1997:
p53 protein expression and increased SSCP mobility shifts in the p53 gene in normal urothelium cultured from smokers

Schmitt, F.C.; Leal, C.; Lopes, C., 1995:
p53 protein expression and nuclear DNA content in breast intraductal proliferations

Tateyama, H.; Eimoto, T.; Tada, T.; Mizuno, T.; Inagaki, H.; Hata, A.; Sasaki, M.; Masaoka, A., 1995:
p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study

Ajiki, T.; Onoyama, H.; Yamamoto, M.; Asaka, K.; Fujimori, T.; Maeda, S.; Saitoh, Y., 1996 :
p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions

Miyagami, M.; Kanou, T.; Nakamura, S., 1996:
P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas

Sato, Y.; Nio, Y.; Song, M.M.; Sumi, S.; Hirahara, N.; Minari, Y.; Tamura, K., 1997:
p53 protein expression as prognostic factor in human pancreatic cancer

Moch, H.; Sauter, G.; Gasser, T.C.; Buchholz, N.; Bubendorf, L.; Richter, J.; Jiang, F.; Dellas, A.; Mihatsch, M.J., 1997:
P53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma

van Gijssel, H.E.; Maassen, C.B.; Mulder, G.J.; Meerman, J.H., 1997:
p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion

Lauritzen, A., F.; Hou-Jensen, K.; Ralfkiaer, E., 1993:
P53 protein expression in Hodgkin's disease

Van Nassauw, L.; Schrevens, A.; Van, D.V.jver, K.; Van Mieghem, F.; Harrisson, F.; Callebaut, M., 1997:
P53 protein expression in avian ovarian follicles

Ro, Y.S.; Cooper, P.N.; Lee, J.A.; Quinn, A.G.; Harrison, D.; Lane, D.; Horne, C.H.W.; Rees, J.L.; Angus, B., 1993:
P53 protein expression in benign and malignant skin tumours

Karamitopoulou, E.; Perentes, E.; Diamantis, I., 1993:
P53 protein expression in central nervous system tumors: An immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies

Karamitopoulou, E.; Perentes, E.; Diamantis, I.; Vogt, U.; Wegmann, W., 1995 :
P53 protein expression in colorectal adenomas: An immunohistochemical study using an antigen retrieval system

Ogawa, Toshiyuki, 1992:
P53 protein expression in colorectal tumors in terms of PCNA and DNA ploidy analysis

Lauritzen, A.F.; Vejlsgaard, G.L.; Hou Jensen, K.; Ralfkiaer, E., 1995:
P53 protein expression in cutaneous T-cell lymphomas

Rajan, P., B.; Scott, D., J.; Perry, R., H.; Griffith, C., D.M., 1997:
P53 protein expression in ductal carcinoma in situ (DCIS) of the breast

Poljak, M.; Cerar, A.; Orlowska, J., 1996:
p53 protein expression in esophageal squamous cell papillomas: a study of 36 lesions

Colecchia, M.; Frigo, B.; Zucchi, A.; Leopardi, O., 1995:
P53 protein expression in fine-needle aspirates of breast cancer: An immunocytochemical assay for identifying high-grade ductal carcinomas

Ruck, P.; Xiao, J.C.; Kaiserling, E., 1994:
P53 protein expression in hepatoblastoma: an immunohistochemical investigation

Katoh, A.; Breier, S.; Stemmler, N.; Specht, S.; Blanock, K.; D'Amico, F., 1996:
p53 protein expression in human breast carcinoma: lack of prognostic potential for recurrence of the disease

Rafki, N.; Liautaud Roger, F.; Devy, L.; Trentesaux, C.; Dufer, J., 1997:
P53 protein expression in human multidrug-resistant CEM lymphoblasts

Paydas, S., 1995:
p53 protein expression in leukemias

Poller, D.N.; Roberts, E.C.; Bell, J.A.; Elston, C.W.; Blamey, R.W.; Ellis, I.O., 1993:
p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

Oka, T.; Baran-Sarker, A.; Teramoto, N.; Yoshino, T.; Akagi, T., 1998:
P53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations

Dei Tos, A.P.; Doglioni, C.; Laurino, L.; Barbareschi, M.; Fletcher, C.D.M., 1993:
P53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue

Aizawa, S.; Sasaki, M.; Wada, R.; Koyama, M.; Yagihashi, S., 1996:
P53 protein expression in pancreatic tumors and its relationship to clinicopathological factors and prognosis

Regezi, J.A.; Zarbo, R.J.; Regev, E.; Pisanty, S.; Silverman, S.; Gazit, D., 1995:
P53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas

Berner, A.; Holm, R.; Naess, A.; Hjortdal, O., 1993:
p53 protein expression in squamocellular carcinomas of the lip

Rudas, M.; Neumayer, R.; Gnant, M.F.X.; Mittelboeck, M.; Jakesz, R.; Reiner, A., 1997:
P53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast

Chaves, P.; Pereira, A.D.as; Pinto, A.; Oliveira, A.G.uveia; Queimado, L.; Gloria, L.; Cardoso, P.; Mira, F.C.sta; Soares, J., 1997:
P53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium

Göhring, U.J.; Scharl, A.; Heckel, C.; Ahr, A.; Crombach, G., 1995:
P53 protein in 204 patients with primary breast carcinoma--immunohistochemical detection and clinical value as a prognostic factor

D.R.sa, G.; Staibano, S.; Barra, E.; Donofrio, V.; Salvatore, G.; Vessecchia, G.; Boscaino, A., 1993:
P53 protein in aggressive and non-aggressive basal cell carcinoma

Casazza, S.; Gambini, C.; Tunesi, G.; Rovida, S.; Caruso, F.; Pastorino, A.; Canepa, M., 1993:
P53 protein in cutaneous melanoma

De-Re, V.; Carbone, A.; De-Vita, S.; Gloghini, A.; Maestro, R.; Gasparotto, D.; Vukosavljevic, T.; Boiocchi, M., 1994:
P53 protein over-expression and p53 gene abnormalities in HIV-1-related non-Hodgkin's lymphomas

Vojtĕsek, B.; Kovarík, J.; Nenutil, R.; Svitáková, M.; Zaloudík, J.; Dolezalová, H.; Rejthar, A.; Lauerová, L., 1995:
p53 protein overexpression associates with growth patterns rather than with metastasizing in operable breast cancer

Rizzi, P.M.; Ryder, S.D.; Portmann, B.; Ramage, J.K.; Naoumov, N.V.; Williams, R., 1996:
p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis

Hussong, J.; Talamonti, M.; Rao, M., 1997:
p53 protein overexpression in infiltrating ductal carcinoma of female breast and its association with lymph node metastasis

van der Kooy, K.; Rookus, M.A.; Peterse, H.L.; van Leeuwen, F.E., 1996:
p53 protein overexpression in relation to risk factors for breast cancer

Matsumoto, H.; Shimura, M.; Omatsu, T.; Okaichi, K.; Majima, H.; Ohnishi, T., 1994:
P53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines

Nork, T.M.; Poulsen, G.L.; Millecchia, L.L.; Jantz, R.G.; Nickells, R.W., 1997:
p53 regulates apoptosis in human retinoblastoma

Perrem, K.; Rayner, J.; Voss, T.; Sturzbecher, H.; Jackson, P.; Braithwaite, A., 1995:
p53 represses SV40 transcription by preventing formation of transcription complexes

Werner, J.A.; Gottschlich, S.; Folz, B.J.; Goeroegh, T.; Lippert, B.M.; Maass, J.D.; Rudert, H., 1997:
P53 serum antibodies as prognostic indicator in head and neck cancer

Ohno, A.; Hirashima, T.; Kubo, A.; Masuda, N.; Takada, M.; Fujiwara, H.; Yasumitsu, T.; Kikui, M.; Fukuoka, M.; Nakagawa, K., 1997:
p53 status and prognosis in stage I-IIIa non-small cell lung cancer

Grignon, D.J.; Caplan, R.; Sarkar, F.H.; Lawton, C.A.; Hammond, E.H.; Pilepich, M.V.; Forman, J.D.; Mesic, J.; Fu, K.K.; Abrams, R.A.; Pajak, T.F.; Shipley, W.U.; Cox, J.D., 1997:
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610

Lowe, S.W.; Bodis, S.; McClatchey, A.; Remington, L.; Ruley, H.E.; Fisher, D.E.; Housman, D.E.; Jacks, T., 1994:
p53 status and the efficacy of cancer therapy in vivo

Debernardis, D.; Siré, E.G.; D.F.udis, P.; Vikhanskaya, F.; Valenti, M.; Russo, P.; Parodi, S.; D'Incalci, M.; Broggini, M., 1997:
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel

Baxendine-Jones, J.; Campbell, I.; Ellison, D., 1997:
p53 status has no prognostic significance in glioblastomas treated with radiotherapy

Radford, I.R., 1994:
P53 status, DNA double-strand break repair proficiency, and radiation response of mouse lymphoid and myeloid cell lines

Pipkin, J.L.; Hinson, W.G.; James, S.J.; Lyn Cook, L.E.; Duffy, P.H.; Feuers, R.J.; Shaddock, J.G.; Aly, K.B.; Hart, R.W.; Casciano, D.A., 1997:
P53 synthesis and phosphorylation in the aging diet-restricted rat following retinoic acid administration

Tokino, T.; Thiagalingam, S.; E.D.iry, W.S.; Waldman, T.; Kinzler, K.W.; Vogelstein, B., 1994:
P53 tagged sites from human genomic DNA

Haapajärvi, T.; Pitkänen, K.; Tsubari, M.; Laiho, M., 1997:
p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle

Roemer, K.; Mueller-Lantzsch, N., 1996:
p53 transactivation domain mutant Q22, S23 is impaired for repression of promoters and mediation of apoptosis

Miyahara, H.; Yane, K.; Naitoh, H.; Konishi, N.; Kitahori, Y.; Matsunaga, T.; Hiasa, Y., 1997:
p53 tumor suppressor gene and ras oncogene mutations in hypopharyngeal squamous cell carcinomas

Coronado, P.J.; Vidart, J.A.; Lopez, J.; Cristobal, I.; Furio, M.A.H.rraiz, V.; Pelayo, A.; Maestro, M.L.; Ortega, M.D.; Rodriguez, R.; Escudero, M., 1997:
P53 tumor suppressor gene in endometrial cancer: Prognostic significance

Gao, H.; Wang, L.D.; Zhou, Q.; Hong, J.Y.; Huang, T.Y.; Yang, C.S., 1994:
p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China

Roa, I.; Villaseca, M.; Araya, J.; Roa, J.; D.A.etxabala, X.; Melo, A.; Ibacache, G., 1997:
P53 tumor suppressor gene protein expression in early and advanced gallbladder carcinoma

Harris, C.C., 1996:
p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment

Frank, J.L.; Bur, M.E.; Garb, J.L.; Kay, S.; Ware, J.L.; Sismanis, A.; Neifeld, J.P., 1994 :
P53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx

Kesari, A.L.kshmi; Chellam, V.G.; Nair, P.P.; Ahmed, I.; Madhavan, J.; Thomas, P.A.; Nair, M.K.ishnan; Pillai, M.R.dhakrishna, 1997:
P53 tumor suppressor protein and tissue proliferative fraction in infiltrating duct carcinoma

Neri, A.; Fracchilla, N.-Stefano; Radaelli, F.; Boletini, A.; Ribera, S.; Migliorini, C.; Trecca, D.; Maiolo, A.-Teresa, 1996:
P53 tumour suppressor gene and RAS oncogenes: Molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia

Lutzker, Stuart, G., 1998:
P53 tumour suppressor gene and germ cell neoplasia

Bartz, C.; Ziske, C.; Wiedenmann, B.; Moelling, K., 1996:
p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells

Nishino, H.; Knöll, A.; Buettner, V.L.; Frisk, C.S.; Maruta, Y.; Haavik, J.; Sommer, S.S., 1995:
p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain

Dimartino, L.; Benini, E.; Faranda, A.; Demontis, B.; Murenu, G.; Ferreli, A.; Daidone, M.; Silvestrtni, R., 1996:
P53, Bcl-2 expression and cell proliferation in benign breast lesions

Weyrer, K.; Feichtinger, H.; Haun, M.; Weiss, G.; Ofner, D.; Weger, A.R.; Umlauft, F.; Grünewald, K., 1996:
p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas

Golusiński, W.; Olofsson, J.; Szmeja, Z.; Majewski, P., 1996:
p53, PCNA and Ki67 in laryngeal cancer

Schammel, D.P.; Bocklage, T., 1996:
p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study

Mateo, M.S.; Sanchez-Beato, M.; Martinez, J.C.; Orfao, A.; Orradre, J.L.; Piris, M.A., 1995:
p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections

Gimenez-Conti, I.B.; Collet, A.M.; Lanfranchi, H.; Itoiz, M.E.; Luna, M.; Xu, H.J.; Hu, S.X.; Benedict, W.F.; Conti, C.J., 1996:
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas

Amortegui, A.J.; Meyer, M.P.; Elborne, V.L.; Amin, R.M., 1995:
P53, Retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positve cervical intraepithelial neoplasia and invasive cancer

Lee, N.K.; Ye, Y.W.; Chen, J.; Li, X.; Waber, P.G.; Nisen, P.D., 1993:
p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract

Nijman, H.W.; Van Der Burg, S.H.; Vierboom, M.P.M.; Houbiers, J.G.A.; Kast, W.M.rtin; Melief, C.J.M., 1994:
p53, a potential target for tumor-directed T cells

Wang, T.H.; Wang, H.S., 1996:
p53, apoptosis and human cancers

Theodorescu, D.; Broder, S.R.; Boyd, J.C.; Mills, S.E.; Frierson, H.F., 1997:
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

Korkolopoulou, P.; Oates, J.; Kittas, C.; Crocker, J., 1994:
p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas

Tierney, L.A.; Hahn, F.F.; Lechner, J.F., 1996:
P53, erbB-2 and K-ras gene alterations are rare in spontaneous and plutonium-239-induced canine lung neoplasia

O'Reilly, P.E.; Raab, S.S.; Niemann, T.H.; Rodgers, J.R.; Robinson, R.A., 1997:
p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomas

Chen, X.; Bargonetti, J.; Prives, C., 1995:
p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis

Kumar, M.G.; Spandau, D.F., 1995:
p53-binding proteins in squamous cell carcinoma and normal human keratinocytes

Jackson, P.; Shield, M.; Buskin, J.; Hawkes, S.; Reed, M.; Perrem, K.; Hauschka, S.D.; Braithwaite, A., 1995:
p53-dependent activation of the mouse MCK gene promoter: identification of a novel p53-responsive sequence and evidence for cooperation between distinct p53 binding sites

Macleod, K.F.; Sherry, N.; Hannon, G.; Beach, D.; Tokino, T.; Kinzler, K.; Vogelstein, B.; Jacks, T., 1995:
P53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

Lowe, S.W.; Ruley, H.E.rl; Jacks, T.; Housman, D.E., 1993:
P53-Dependent apoptosis modulates the cytotoxicity of anticancer agents

Symonds, H.; Krall, L.; Remington, L.; Saenz Robles, M.; Lowe, S.; Jacks, T.; Van Dye, T., 1994:
P53-Dependent apoptosis suppresses tumor growth and progression in vivo

Huang, L.C.; Clarkin, K.C.; Wahl, G.M., 1996:
p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts

Ishizaka, Y.; Chernov, M.V.; Burns, C.M.; Stark, G.R., 1995:
p53-dependent growth arrest of REF52 cells containing newly amplified DNA

Ohtsubo, T.; Wang, X.; Takahashi, A.; Ohnishi, K.; Saito, H.; Song, C.W.; Ohnishi, T., 1997:
p53-dependent induction of WAF1 by a low-pH culture condition in human glioblastoma cells

Isaacs, J.S.; Chiao, C.; Merrick, B.A.; Selkirk, J.K.; Barrett, J.C.; Weissman, B.E., 1997:
p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line

Rosselli, F.; Ridet, A.; Soussi, T.; Duchaud, E.; Alapetite, C.; Moustacchi, E., 1995:
p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia

Ewen, M.E.; Oliver, C.J.; Sluss, H.K.; Miller, S.J.; Peeper, D.S., 1995:
p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest

Li, Y.; Chopp, M.; Zhang, Z.G.; Zaloga, C.; Niewenhuis, L.; Gautam, S., 1994:
p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats

Subramanian, T.; Tarodi, B.; Chinnadurai, G., 1995:
p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins

Shibata, M.A.; Maroulakou, I.G.; Jorcyk, C.L.; Gold, L.G.; Ward, J.M.; Green, J.E., 1996:
p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma

Parker, S.B.; Eichele, G.; Zhang, P.; Rawls, A.; Sands, A.T.; Bradley, A.; Olson, E.N.; Harper, J.W.de; Elledge, S.J., 1995:
P53-Independent expression of p21-Cip1 in muscle and other terminally differentiating cells

Werness, B.A.; Wang, H.Q.; Chance, J.; Goldstein, D.J., 1997 :
p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix

DiGiuseppe, J.A.; Redston, M.S.; Yeo, C.J.; Kern, S.E.; Hruban, R.H., 1995:
p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma

Spitkovsky, D.; Aengeneyndt, F.; Braspenning, J.; von Knebel Doeberitz, M., 1996:
p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene

Zhang, W.; Grasso, L.; McClain, C.D.; Gambel, A.M.; Cha, Y.; Travali, S.; Deisseroth, A.B.; Mercer, W.E., 1995:
p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation

Shibata, Y.; Nishimura, S.; Okuyama, A.; Nakamura, T., 1996:
p53-independent induction of apoptosis by cyclin-dependent kinase inhibition

Hirata, H.; Cadet, J.L.d, 1997:
P53-Knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies

Haupt, Y.; Rowan, S.; Oren, M., 1995:
p53-mediated apoptosis in HeLa cells can be overcome by excess pRB

Haupt, Y.; Oren, M., 1996:
p53-mediated apoptosis: mechanisms and regulation

Yonish-Rouach, E.; Grunwald, D.; Wilder, S.; Kimchi, A.; May, E.; Lawrence, J.J.; May, P.; Oren, M., 1993:
p53-mediated cell death: relationship to cell cycle control

Puisieux, A.; Ji, J.; Guillot, C.; Legros, Y.; Soussi, T.; Isselbacher, K.; Ozturk, M., 1995:
p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus

Oberosler, P.; Hloch, P.; Ramsperger, U.; Stahl, H., 1993:
p53-catalyzed annealing of complementary single-stranded nucleic acids

Haas Kogan, D.A.; Yount, G.; Haas, M.; Levi, D.; Kogan, S.S.; Hu, L.; Vidair, C.; Deen, D.F.; Dewey, W.C.; Israel, M.A., 1996:
P53-dependent G-1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma

Akutsu, N.; Shirasawa, H.; Asano, T.; Isono, K.; Simizu, B., 1996:
p53-Dependent and -independent transactivation by the E6 protein of human papillomavirus type 16

Okamoto, K.; Kamibayashi, C.; Serrano, M.; Prives, C.; Mumby, M.C.; Beach, D., 1996:
p53-dependent association between cyclin G and the B' subunit of protein phosphatase 2A

Dietrich, C.; Bartsch, T.; Schanz, F.; Oesch, F.; Weiser, R.J., 1996:
P53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts

Renzing, J.; Lane, D.P., 1995:
p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts

Ohnishi, T.; Wang, X.; Ohnishi, K.; Matsumoto, H.; Takahashi, A., 1996:
p53-dependent induction of WAF1 by heat treatment in human glioblastoma cells

Lopes, U.G.zos; Erhardt, P.; Yao, R.; Cooper, G.M., 1997:
P53-dependent induction of apoptosis by proteasome inhibitors

Dulic, V.; Kaufmann, W.K.; Wilson, S.J.; Tlsty, T.D.; Lees, E.; Harper, J.W.de; Elledge, S.J.; Reed, S.I., 1994:
P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest

Thottassery, J.V.; Zambetti, G.P.; Arimori, K.; Schuetz, E.G.; Schuetz, J.D., 1997:
P53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents

Ewen, M.E., 1996:
p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced G1 cell cycle arrest

Lanni, J.S.; Lowe, S.W.; Licitra, E.J.; Liu, J.O.; Jacks, T., 1997:
P53-independent apoptosis induced by paclitaxel through an indirect mechanism

Morita, N.; Kiryu, S.; Kiyama, H., 1996:
p53-independent cyclin G expression in a group of mature neurons and its enhanced expression during nerve regeneration

Strasberg Rieber, M.; Welch, D.R.; Miele, M.E.; Rieber, M., 1996:
p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells

Yoshida, K.; Murohashi, I.; Hirashima, K., 1996:
p53-independent induction of p21 (WAF1/CIP1) during differentiation of HL-60 cells by tumor necrosis factor alpha

Chen, Y.; Cipriano, S.; Sarkar, F.; Ware, J.; Arenkiel, J., 1995:
P53-independent induction of p21(waf1) pathway is preserved during tumor progression

Serfas, M.S.; Goufman, E.; Feuerman, M.H.; Gartel, A.L.; Tyner, A.L., 1997:
p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication

Howard, J.; Ung, Y.; Adachi, D.; Ben-David, Y., 1996:
p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias

Jean, D.; Gendron, D.; Delbecchi, L.; Bourgaux, P., 1997:
p53-mediated DNA renaturation can mimic strand exchange

Bristow, R.G.; Brail, L.; Jang, A.; Peacock, J.; Chung, S.; Benchimol, S.; Hill, R.P., 1996:
P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection

Weinberg, W.C.; Azzoli, C.G.; Chapman, K.; Levine, A.J.; Yuspa, S.H., 1995:
p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein

Vogt, T.; Zipperer, K.H.; Vogt, A.; Hoelzel, D.; Landthaler, M.; Stolz, W., 1997:
P53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin

Tisdale, E.J.; Plutner, H.; Matteson, J.; Balch, W.E., 1997:
p53/58 binds COPI and is required for selective transport through the early secretory pathway

Hung, J.; Anderson, R., 1997:
p53: functions, mutations and sarcomas

Oka, K.; Nakano, T.; Arai, T., 1993:
P53CM1 expression is not associated with prognosis in uterine cervical carcinoma

Eliyahu, D.; Evans, S.; Rosen, N.; Eliyahu, S.; Zwiebel, J.; Paik, S.; Lippman, M., 1994:
P53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells

Quéva, C.; Leprince, D.; Stéhelin, D.; Vandenbunder, B., 1993:
p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo

Chambaut-Guérin, A.M.; Rouher, C.; Gauthereau, X., 1997:
p55 tumour necrosis factor receptors distribution in neuroblastoma cells

Kato, T.; Sawamura, Y.; Tada, M.; Sakuma, S.; Sudo, M.; Abe, H., 1995:
p55 and p75 tumor necrosis factor receptor expression on human glioblastoma cells

Butler, D.M.; Feldmann, M.; D.P.dova, F.; Brennan, F.M., 1994:
p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts

Waage, A.; Liabakk, N.; Lien, E.; Lamvik, J.; Espevik, T., 1992:
p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia

Abraham, E.; Glauser, M., P.; Butler, T.; Garbino, J.; Gelmont, D.; Laterre, P., F.; Kudsk, K.; Bruining, H., A.; Otto, C.; Tobin, E.; Zwingelstein, C.; Lesslauer, W.; Leighton, A., 1997:
P55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial

Feng, S.; Barthold, S.W.; Telford, S.R.; Fikrig, E., 1996:
P55, an immunogenic but nonprotective 55-kilodalton Borrelia burgdorferi protein in murine Lyme disease

Raab, M.; Cai, Y.C.; Bunnell, S.C.; Heyeck, S.D.; Berg, L.J.; Rudd, C.E., 1995:
p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation

Francesconi, S.; Grenon, M.; Bouvier, D.; Baldacci, G., 1997:
p56(chk1) protein kinase is required for the DNA replication checkpoint at 37 degrees C in fission yeast

Yamada, H.; Kong, Y.Y.; Kishihara, K.; Mak, T.W.; Nomoto, K., 1997:
P56-lck in not essential for the T-cell response to allo-MHC antigens

Duplay, P.; Thome, M.; Hervé, F.; Acuto, O., 1994:
p56lck interacts via its src homology 2 domain with the ZAP-70 kinase

Couture, C.; Baier, G.; Altman, A.; Mustelin, T., 1994:
p56lck-independent activation and tyrosine phosphorylation of p72syk by T-cell antigen receptor/CD3 stimulation

Ramos-Morales, F.; Douté, M.; Fischer, S., 1994:
P56lck: a transducing protein that binds to SH2 containing proteins and to phosphotyrosine containing proteins

Kharbanda, S.; Yuan, Z.M.; Taneja, N.; Weichselbaum, R.; Kufe, D., 1994:
p56/p53lyn tyrosine kinase activation in mammalian cells treated with mitomycin C

D.S.mma, M.M.ddalena; Nuti, S.; Telford, J.L.; Baldari, C.T., 1995:
P561ck plays a key role in transducing apoptotic signals in T cells

Bland, M.M.; McDonald, O.B.; Carrera, A.C., 1994:
p56lck phosphorylation by Ca2+/calmodulin-dependent protein kinase type II

Fischer, S.; Marie-Cardine, A.; Ramos-Morales, F.; Bougeret, C.; Soula, M.; Maridonneau-Parini, I.; Benarous, R., 1994:
P56lck a lymphocytes specific protein tyrosine kinase: Activation, regulation and signal transduction

Wang, S.; Lehr, R.; Stevis, P.; Wang, X.M.; Trevillyan, J.; Faltynek, C.R., 1994:
p56lck interactions accelerate autophosphorylation and enhance activity toward exogenous substrates

Matsuoka, S.; Edwards, M.C.; Bai, C.; Parker, S.; Zhang, P.; Baldini, A.; Harper, J.W.; Elledge, S.J., 1995:
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

Bates, William, R., 1997:
P58, a cytoskeletal protein, is associated with muscle cell determinants in ascidian eggs

Timson Gauen, L.K.; Kong, A.N.; Samelson, L.E.; Shaw, A.S., 1992:
p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain

Bare, D.J.; Lauder, J.M.; Wilkie, M.B.; Maness, P.F., 1993:
p59fyn in rat brain is localized in developing axonal tracts and subpopulations of adult neurons and glia

Kanazawa, S.; Ilic, D.; Hashiyama, M.; Nomura, T.; Yamamoto, T.; Suda, T.; Aizawa, S., 1996:
P59-fyn-p125-FAK cooperation in development of CD+ CD8+ thymocytes

Naito, Y.; Shiraishi, H.; Inoue, T., 1998:
P5abc of the Tetrahymena ribozyme consists of three functionally independent elements

Huang, M.; Orenstein, J.M.; Martin, M.A.; Freed, E.O., 1995:
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease

Weinkove, D.; Leevers, S.J.; MacDougall, L.K.; Waterfield, M.D., 1997:
p60 is an adaptor for the Drosophila phosphoinositide 3-kinase, Dp110

Hamaguchi, M.; Matsuyoshi, N.; Ohnishi, Y.; Gotoh, B.; Takeichi, M.; Nagai, Y., 1993:
p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system

Rosa, J.L.; Casaroli-Marano, R.P.; Buckler, A.J.; Vilaró, S.; Barbacid, M., 1996:
p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins

Wang, L.L.; Richard, S.; Shaw, A.S., 1995:
P62 association with RNA is regulated by tyrosine phosphorylation

Vadlamudi, R.K.; Joung, I.; Strominger, J.L.; Shin, J., 1996:
p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins

Sikorski, R.S.; Michaud, W.A.; Hieter, P., 1993:
p62cdc23 of Saccharomyces cerevisiae: a nuclear tetratricopeptide repeat protein with two mutable domains

Carpino, N.; Wisniewski, D.; Strife, A.; Marshak, D.; Kobayashi, R.; Stillman, B.; Clarkson, B., 1997:
P62-dok: A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells

Gallagher, I.M.; Alfa, C.E.; Hyams, J.S., 1993:
p63cdc13, a B-type cyclin, is associated with both the nucleolar and chromatin domains of the fission yeast nucleus

Nishitani, H.; Nurse, P., 1995:
P65-cdc18 plays a major role controlling the initiation of DNA replication in fission yeast

Xie, Y.; Hung, M.C., 1996:
p66Shc isoform down-regulated and not required for HER-2/neu signaling pathway in human breast cancer cell lines with HER-2/neu overexpression

Gupta, S.; Bose, A.; Chatterjee, N.; Saha, D.; Wu, S.; Gupta, N.K., 1997:
p67 transcription regulates translation in serum-starved and mitogen-activated KRC-7 cells

Uhlinger, D.J.; Taylor, K.L.; Lambeth, J.D., 1994:
p67-phox enhances the binding of p47-phox to the human neutrophil respiratory burst oxidase complex

Gilfillan, A.; Warner, J.P.; Kirk, J.M.; Marshall, T.; Greening, A.; Ho, L.P.; Hargreave, T.; Stack, B.; McIntyre, D.; Davidson, R.; Dean, J.C.; Middleton, W.; Brock, D.J., 1998:
P67L: a cystic fibrosis allele with mild effects found at high frequency in the Scottish population

Lukins, P.B.; Post, A.; Walker, P.J.; Larkum, A.W., 1996:
P680(+) reduction in oxygen-evolving Photosystem II core complexes

Vogel, L.B.; Fujita, D.J., 1995:
p70 phosphorylation and binding to p56lck is an early event in interleukin-2-induced onset of cell cycle progression in T-lymphocytes

Wang, X.; Proud, C.G., 1997:
p70 S6 kinase is activated by sodium arsenite in adult rat cardiomyocytes: roles for phosphatidylinositol 3-kinase and p38 MAP kinase

Sugiyama, H.; Papst, P.; Gelfand, E.W.; Terada, N., 1996:
P70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr-22

Messier, H.; Fuller, T.; Mangal, S.; Brickner, H.; Igarashi, S.; Gaikwad, J.; Fotedar, R.; Fotedar, A., 1993:
p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene

Bragado, M.J.; Groblewski, G.E.; Williams, J.A., 1997:
p70s6k is activated by CCK in rat pancreatic acini

Morgan, P.J.; Barrett, P.; Davidson, G.; Lawson, W.; Hazlerigg, D., 1994:
p72, a marker protein for melatonin action in ovine pars tuberalis cells: its regulation by protein kinase A and protein kinase C and differential secretion relative to prolactin

Nagai, K.; Inazu, T.; Yamamura, H., 1994:
p72syk is activated by vanadate plus H2O2 in porcine platelets and phosphorylates GTPase activating protein on tyrosine residue(s)

Lamm, G.M.; Nicol, S.M.; Fuller-Pace, F.V.; Lamond, A.I., 1996:
p72: a human nuclear DEAD box protein highly related to p68

Jost, C.A.; Marin, M.C.; Kaelin, W.G.Jr, 1997:
P73 is a human p53-related protein that can induce apoptosis

Kahle, P.; Barker, P.A.; Shooter, E.M.; Hertel, C., 1994:
p75 nerve growth factor receptor modulates p140trkA kinase activity, but not ligand internalization, in PC12 cells

Kanik, A.B.; Yaar, M.; Bhawan, J., 1996:
P75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma

Moga, M.M.; Duong, T., 1997:
P75 neurotrophin receptor immunoreactivity in the aged human hypothalamus

Conti, G.; Stoll, G.; Scarpini, E.; Baron, P.L.; Bianchi, R.; Livraghi, S.; Scarlato, G., 1997:
p75 neurotrophin receptor induction and macrophage infiltration in peripheral nerve during experimental diabetic neuropathy: possible relevance on regeneration

Hadari, Y.R.; Haring, H.U.; Zick, Y., 1997:
p75, a member of the heat shock protein family, undergoes tyrosine phosphorylation in response to oxidative stress

Lee, K.F.; Davies, A.M.; Jaenisch, R., 1994:
p75-deficient embryonic dorsal root sensory and neonatal sympathetic neurons display a decreased sensitivity to NGF

Muller, Y.; Clos, J., 1997:
P75-LNTR: An enigmatic neurotrophin receptor

Canossa, M.; Twiss, J.L.; Verity, A.N.; Shooter, E.M., 1996 :
p75(NGFR) and TrkA receptors collaborate to rapidly activate a p75(NGFR)-associated protein kinase

Bredesen, D., E.; Rabizadeh, S., 1997:
P75-NTR and apoptosis: Trk-dependent and Trk-independent effects

Higuchi, M.; Aggarwal, B.B., 1993:
P80 form of the human tumor necrosis factor receptor is involved in DNA fragmentation

Okamura, H.; Resh, M.D., 1995:
p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells

Puvion-Dutilleul, F.; Besse, S.; Chan, E.K.; Tan, E.M.; Puvion, E., 1995:
p80-coilin: a component of coiled bodies and interchromatin granule-associated zones

Frankenberg, N.; Hager Braun, C.; Feiler, U.; Fuhrmann, M.; Rogi, H.; Schneebauer, N.; Nelson, N.; Hauska, G., 1996:
P840-reaction centers from Chlorobium tepidum-quinone analysis and functional reconstitution into lipid vesicles

Inukai, K.; Funaki, M.; Ogihara, T.; Katagiri, H.; Kanda, A.; Anai, M.; Fukushima, Y.; Hosaka, T.; Suzuki, M.; Shin, B.C.; Takata, K.; Yazaki, Y.; Kikuchi, M.; Oka, Y.; Asano, T., 1997:
p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulin

Talve, L.A.; Collan, Y.U.; Ekfors, T.O., 1997:
P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study

Aronica, M.G.; Brizzi, M.F.; Dentelli, P.; Rosso, A.; Yarden, Y.; Pegoraro, L., 1996:
p91 STAT1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells

Nabeshima, K.; Kurooka, H.; Takeuchi, M.; Kinoshita, K.; Nakaseko, Y.; Yanagida, M., 1995:
p93dis1, which is required for sister chromatid separation, is a novel microtubule and spindle pole body-associating protein phosphorylated at the Cdc2 target sites

Kalab, P.; Visconti, P.; Leclerc, P.; Kopf, G.S., 1994:
p95, the major phosphotyrosine-containing protein in mouse spermatozoa, is a hexokinase with unique properties

Romero, F.; Dargemont, C.; Pozo, F.; Reeves, W.H.; Camonis, J.; Gisselbrecht, S.; Fischer, S., 1996:
p95vav associates with the nuclear protein Ku-70

Tuosto, L.; Michel, F.; Acuto, O., 1996:
P95-vav associated with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells

Gilboa-Garber, N.; Sudakevitz, D.; Sheffi, M.; Sela, R.; Levene, C., 1994:
PA-I and PA-II lectin interactions with the ABO(H) and P blood group glycosphingolipid antigens may contribute to the broad spectrum adherence of Pseudomonas aeruginosa to human tissues in secondary infections

Rososhansky, S.; Szymanski, I., O., 1994:
PA-IgG on platelet subpopulations of different buoyant densities: High levels on the low density population is an artifact

Gray, C.W.; Slaughter, C.A.; DeMartino, G.N., 1994:
PA28 activator protein forms regulatory caps on proteasome stacked rings

Kandil, E.; Kohda, K.; Ishibashi, T.; Tanaka, K.; Kasahara, M., 1997:
PA28 subunits of the mouse proteasome: primary structures and chromosomal localization of the genes

Mott, J.D.; Pramanik, B.C.; Moomaw, C.R.; Afendis, S.J.; DeMartino, G.N.; Slaughter, C.A., 1994:
PA28, an activator of the 20 S proteasome, is composed of two nonidentical but homologous subunits

Ma, C.P.; Willy, P.J.; Slaughter, C.A.; DeMartino, G.N., 1993:
PA28, an activator of the 20 S proteasome, is inactivated by proteolytic modification at its carboxyl terminus

DeMartino, G.N.; Moomaw, C.R.; Zagnitko, O.P.; Proske, R.J.; Chu-Ping, M.; Afendis, S.J.; Swaffield, J.C.; Slaughter, C.A., 1994:
PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family

Adami, M.; Sartore, M.; Nicolini, C., 1995:
PAB: A newly designed potentiometric alternating biosensor system

Sandrucci, P.; Merlo, G.; Genon, G.; Meucci, L., 1995:
PAC Activity vs By-Product Precursors In Water Disinfection

Kazmierczak, B.; Bol, S.; Wanschura, S.; Bartnitzke, S.; Bullerdiek, J., 1996:
PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line

Rohan, P., J.; Davis, P.; Moskaluk, C., A.; Kearns, M.; Krutzsch, H.; Siebenlist, U.; Kelly, K., 1993:
PAC-1: A mitogen-induced nuclear protein tyrosine phosphatase

De-Girolamo, P.; Arcamone, N.; Rosica, A.; Gargiulo, G., 1998:
PACAP (pituitary adenylate cyclase-activating peptide)-like immunoreactivity in the gill arch of the goldfish, Carassius auratus: Distribution and comparison with VIP

Linden, A.; Cardell, L.O.af; Yoshihara, S.; Stjarne, P.; Nadel, J.A., 1998:
PACAP 1-38 as an inhaled bronchodilator in guinea pigs in vivo

Krempels, K.; Usdin, T.B.; Harta, G.; Mezey, E., 1995:
PACAP acts through VIP type 2 receptors in the rat testis

Filipsson, K.; Sundler, F.; Hannibal, J.; Ahren, B., 1998:
PACAP and PACAP receptors in insulin producing tissues: Localization and effects

Parkman, H.P.; Pagano, A.P.; Ryan, J.P., 1997:
PACAP and VIP inhibit pyloric muscle through VIP/PACAP-preferring receptors

Hezareh, M.; Schlegel, W.; Rawlings, S.R., 1996:
PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta

Schmidt, W.E.; Seebeck, J.; Höcker, M.; Schwarzhoff, R.; Schäfer, H.; Fornefeld, H.; Morys-Wortmann, C.; Fölsch, U.R.; Creutzfeldt, W., 1993:
PACAP and VIP stimulate enzyme secretion in rat pancreatic acini via interaction with VIP/PACAP-2 receptors: additive augmentation of CCK/carbachol-induced enzyme release

Koves, K.; Kantor, O.; Scammell, J.G.; Arimura, A., 1998:
PACAP colocalizes with luteinizing and follicle-stimulating hormone immunoreactivities in the anterior lobe of the pituitary gland

Pisegna, J.R.; Leyton, J.; Coelho, T.; Hida, T.; Jakowlew, S.; Birrer, M.; Fridkin, M.; Gozes, I.; Moody, T.W., 1997:
PACAP hybrid: A new PACAP receptor antagonist

Shibuya, I.; Noguchi, J.; Tanaka, K.; Harayama, N.; Inoue, U.; Kabashima, N.; Ueta, Y.; Hattori, Y.; Yamashita, H., 1998:
PACAP increases the cytosolic Ca2+ concentration and stimulates somatodendritic vasopressin release in rat supraoptic neurons

Seebeck, J.; Schmidt, W.E.; Kilbinger, H.; Neumann, J.; Zimmermann, N.; Herzig, S., 1996:
PACAP induces bradycardia in guinea-pig heart by stimulation of atrial cholinergic neurones

Onali, P.; Olianas, M.C., 1994:
PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species

Katsoulis, S.; Clemens, A.; Schwörer, H.; Creutzfeldt, W.; Schmidt, W.E., 1993:
PACAP is a stimulator of neurogenic contraction in guinea pig ileum

Chik, C.L.; Li, B.; Ogiwara, T.; Ho, A.K.; Karpinski, E., 1996:
PACAP modulates L-type Ca2+ channel currents in vascular smooth muscle cells: involvement of PKC and PKA

Draoui, M.; Hida, T.; Jakowlew, S.; Birrer, M.; Zia, F.; Moody, T.W., 1996:
PACAP stimulates c-fos mRNAs in small cell lung cancer cells

Watanabe, T.; Shimamoto, N.; Takahashi, A.; Fujino, M., 1995:
PACAP stimulates catecholamine release from adrenal medulla: a novel noncholinergic secretagogue

Anderson, S.T.; Curlewis, J.D., 1998:
PACAP stimulates dopamine neurons activity in the medial basal hypothalamus and inhibits prolactin

Yokota, C.; Kawai, K.; Ohashi, S.; Watanabe, Y.; Yamashita, K., 1995:
PACAP stimulates glucose output from the perfused rat liver

Filipsson, K.; Pacini, G.; Scheurink, A.J.; Ahrén, B., 1998:
PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice

Onaga, T.; Okamoto, K.; Harada, Y.; Mineo, H.; Kato, S., 1997:
PACAP stimulates pancreatic exocrine secretion via the vagal cholinergic nerves in sheep

Schäfer, H.; Zheng, J.; Gundlach, F.; Günther, R.; Schmidt, W.E., 1996:
PACAP stimulates transcription of c-Fos and c-Jun and activates the AP-1 transcription factor in rat pancreatic carcinoma cells

Kienlen Campard, P.; Crochemore, C.; René, F.; Monnier, D.; Koch, B.; Loeffler, J.P., 1997:
PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway

Nilsson, Siv, F.E., 1994:
PACAP-27 and PACAP-38: vascular effects in the eye and some other tissues in the rabbit

Hirose, M.; Furukawa, Y.; Nagashima, Y.; Lakhe, M.; Miyashita, Y.; Chiba, S., 1997:
PACAP-27 causes negative and positive dromotropic effects in anesthetized dogs

Barnhart, D.C.; SarosiGeorge, A.Jr.; Mulholland, M.W., 1997:
PACAP-38 causes phospholipase C-dependent calcium signaling in rat acinar cell line

Liu, G.J.; Madsen, B.W., 1997:
PACAP38 modulates activity of NMDA receptors in cultured chick cortical neurons

Desai, B.J.; Burrin, J.M., 1994:
PACAP-38 positively regulates glycoprotein hormone alpha-gene expression in placental cells

Cardell, L.O.af; Stjarne, P.; Wagstaff, S.J.; Agusti, C.; Nadel, J.A., 1997:
PACAP-induced plasma extravasation in rat skin

Takeuchi, K.; Takehara, K.; Kato, S.; Yagi, K., 1997:
PACAPs stimulate duodenal bicarbonate secretion at PACAP receptors in the rat

Wasley, L.C.; Rehemtulla, A.; Bristol, J.A.drew; Kaufman, R.J., 1993:
PACE/furin can process the vitamin K-dependent pro-factor IX precursor with the secretory pathway

Rehemtulla, A.; Barr, P.J.; Rhodes, C.J.; Kaufman, R.J., 1993 :
PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE

Hosaka, M.; Murakami, K.; Nakayama, K., 1994:
PACE4 is a ubiquitous endoprotease that has similar but not identical substrate specificity to other Kex2-like processing endoproteases

Johnson, R.C.; Darlington, D.N.; Hand, T.A.; Bloomquist, B.T.; Mains, R.E., 1994:
PACE4: a subtilisin-like endoprotease prevalent in the anterior pituitary and regulated by thyroid status

Mains, R.E.; Berard, C.A.; Denault, J.B.; Zhou, A.; Johnson, R.C.; Leduc, R., 1997:
PACE4: a subtilisin-like endoprotease with unique properties

Svahn, G.; Holtas, S.; Larsson, E.-Marie; Bengtsson, E.; Ehn, A., 1994:
PACS for radiology conferences: Improvement of application software

Kondoh, H.; Ikezoe, J.; Mori, Y.; Nakamura, H.; Inamura, K.; Kozuka, T., 1994:
PACS in Osaka University Hospital

Wan, L.; Molloy, S.S.; Thomas, L.; Liu, G.; Xiang, Y.; Rybak, S.L.nn; Thomas, G., 1998:
PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization

Bergstrom, S.; Karner, G., 1994:
PACS-RIS interconnection: Results of a feasibility study

Plomann, M.; Lange, R.; Vopper, G.; Cremer, H.; Heinlein, U.A.O.; Scheff, S.; Baldwin, S.A.; Leitges, M.; Cramer, M.; Paulsson, M.; Barthels, D., 1998:
PACSIN, a brain protein that is upregulated upon differentiation into neuronal cells

Narbaitz, R.M.; Droste, R.L.; Fernandes, L.; Kennedy, K.J.; Ball, D., 1997:
PACT process for treatment of Kraft mill effluent

Patel, R.C.; Sen, G.C., 1998:
PACT, a protein activator of the interferon-induced protein kinase, PKR

Clausen, M.; Lamb, C.J.; Megnet, R.; Doerner, P.W., 1994:
PAD1 encodes phenylacrylic acid decarboxylase which confers resistance to cinnamic acid in Saccharomyces cerevisiae

Del Principe, D.; Menichelli, A.; D.G.ulio, S.; D.M.tteis, W.; Cianciulli, P.; Papa, G., 1993:
PADGEM/GMP-140 expression on platelet membranes from homozygous beta thalassaemic patients

Winther, K.; Kharazmi, A.; Himmelstrup, H.; Drabaek, H.; Mehlsen, J., 1994:
PADMA-28, a botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudication

Hohnloser, J., H.; Puerner, F., 1992:
PADS (Patient Archiving and Documentation System): A computerized patient record with educational aspects

Arthur, J.F.; Shahin, S.; Dusting, G.J., 1995:
PAF Antagonists Block Induction Of Nitric Oxide Synthase In Cultured Macrophages and Vascular Smooth Muscle Cells

Takakuwa, T.; Endo, S.; Nakae, H.; Kikichi, M.; Inada, K.; Yoshida, M., 1994:
PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis

Adachi, T.; Aoki, J.; Manya, H.; Asou, H.; Arai, H.; Inoue, K., 1997:
PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells

Beyer, A.J.; Smalley, D.M.; Shyr, Y.M.; Wood, J.G.; Cheung, L.Y., 1998:
PAF and CD18 mediate neutrophil infiltration in upper gastrointestinal tract during intra-abdominal sepsis

Hattori, M.; Aoki, J.; Arai, H.; Inoue, K., 1996:
PAF and PAF acetylhydrolase in the nervous system

Tan, X.; Sun, X.; Gonzalez-Crussi, F., X.; Gonzalez-Crussi, F.; Hsueh, W., 1994:
PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: Quantitative analysis by competitive PCR

Dupuis, F.; Dulery, C.; Praloran, V.; Denizot, Y., 1996:
PAF and haematopoiesis XII: Macrophage colony-stimulating factor (M-CSF) decreases platelet-activating factor (PAF) acetylhydrolase production in macrophagic J774 cells

Denizot, Y.; Praloran, V., 1994:
PAF and Haematopoiesis. I. 5-Fluoro-Uracil Induces PAF Production in Haematopoietic Organs of Rats

Denizot, Y.; Trimoreau, F.; Dupuis, F.; Verger, C.; Praloran, V., 1995:
PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow

Denizot, Y.; Dupuis, F.; Comte, L.; Dulery, C.; Praloran, V., 1995:
PAF and haematopoiesis: IV. Modifications of spleen and thymus PAF contents after a single dose of the chemotherapeutic drug 5-fluorouracil in mice

Denizot, Y.; Dupuis, F.; Trimoreau, F.; Verger, C.; Allegraud, A.; Praloran, V., 1996:
PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells

Dupuis, F.; Denizot, Y.; Fixe, P.; Dulery, C.; Praloran, V., 1996:
PAF and haematopoiesis: X. Macrophage colony-stimulating factor and granulocyte macrophage colony-stimulating factor enhance platelet-activating factor acetylhydrolase production by human blood-derived macrophages

Denizot, Y.; Dupuis, F.; Roullet, B.; Praloran, V., 1994:
PAF and hematopoiesis. II. Elevated levels of plasma PAF acetylhydrolase after rapid infusion of 5-fluorouracil in cancer patients

Denizot, Y.; Rougier, F.; Dupuis, F.; Verger, C.; Dulery, C.; Laskar, M.; Aldigier, J.C.; Praloran, V., 1996:
PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells

Catalán, R.E.; Martínez, A.M.; Aragonés, M.D.; Garde, E.; Lombardía, M.; Ortega, P., 1993:
PAF and thrombin actions in platelets are selectively affected by a new 1,4-dihydropyridine derivative

Ma, Y.; Han, G.Q.; Wang, Y.Y., 1993:
PAF antagonistic benzofuran neolignans from Piper kadsura

Bazan, H.E.; Tao, Y., 1997:
PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration

DeFily, D.V.; Kuo, L.; Chilian, W.M., 1996:
PAF attenuates endothelium-dependent coronary arteriolar vasodilation

Becker, K.; Heinroth Hoffman, I.; Giessler, C.; Poenicke, K.; Brodde, O.E., 1995:
PAF effect on eicosanoid release in neonatal rat cardiomyocytes

Hughes, H.; Sands, M.A.; Mcguire, G.M.; Taylor, A.A., 1994:
PAF formation by H-2O-2-stimulated perfused canine carotid arteries

Capasso, F.; Tavares, I.A.; Bennett, A., 1992:
PAF formation by human gastrointestinal mucosa/submucosa in-vitro: release by ricinoleic acid, and inhibition by 5-aminosalicylic acid

Shibamoto, T.; Yamaguchi, Y.; Hayashi, T.; Saeki, Y.; Kawamoto, M.; Koyama, S., 1993:
PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs

Gao, Y.; Zhou, H.; Raj, J.U., 1995:
PAF induces relaxation of pulmonary arteries but contraction of pulmonary veins in the ferret

Ribaldi, E.; Guerra, M.; Mezzasoma, A.M.; Staffolani, N.; Goracci, G.; Gresele, P., 1998:
PAF levels in saliva are regulated by inflammatory cells

Rocha, F.A.C.; Andrade, L.E.C.; Russo, M.; Jancar, S., 1997:
PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats

Asmis, R.; Dennis, E.A., 1994:
PAF stimulates cAMP formation in P388D-1 macrophage-like cells via the formation and secretion of prostaglandin E-2 in an autocrine fashion

Herrero-Beaumont, G.; Egido, J., 1997:
PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage

Foster, A.P.; Cunningham, F.M., 1994:
PAF- and LTB-4-induced migration of eosinophils and neutrophils isolated from horses with allergic skin disease

Dentan, C.; Lesnik, P.; Chapman, M.J.; Ninio, E., 1994:
PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation

Karabina, S.-Athena, P.; Elisaf, M., C.; Goudevenos, J.; Siamopoulos, K., C.; Sideris, D.; Tselepis, A., D., 1996:
PAF-acetylhydrolase activity on Lp(a) before and during Cu-2+-induced oxidative modification in vitro

Zellweger, R.; Ayala, A.; Schmand, J.F.; Morrison, M.H.; Chaudry, I.H., 1995:
PAF-antagonist administration after hemorrhage-resuscitation prevents splenocyte immunodepression

Kertscher, H.P., 1997:
PAF-antagonists with lipid structure. Part 6:P Alkylpropanediol lipids with acyl and ether structure in position C-3 of the backbone and heterocyclic head groups; synthesis, characterization and structure-activity relationship

Tselepis, A.D.; Dentan, C.; Karabina, S.A.; Chapman, M.J.; Ninio, E., 1995:
PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

Longphre, M.; Zhang, L.Y.; Paquette, N.; Kleeberger, S.R., 1996:
PAF-induced airways hyperreactivity is modulated by mast cells in mice

Becker, K.; Lueddeckens, G.; Grupe, R.; Foerster, W., 1993:
PAF-induced death in NMRI mice: A suitable shock model for testing new PAF receptor antagonists: Correlation with eicosanoid related substances

Shindo, K.; Koide, K.; Fukumura, M., 1997:
PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro

Webber, S.E.; Kitt, A.; Yurdakos, E.; Widdicombe, J.G., 1997:
PAF-induced secretory hyperresponsiveness in the ferret trachea to bradykinin and its pharmacological inhibition

Okamoto, Y.; Yoshida, H.; Ino, M.; Nakamura, S.; Okamoto, G.; Mizoguchi, K.; Suzuki, Y.; Sugatani, J.; Miwa, M., 1993:
PAF-releasing factor in human serum and inflammatory exudate

Schnuch, Axel, 1996:
PAFS: Population-adjusted frequency of sensitization: (I). Influence of sex and age

Vanegas, H.; Tortorici, V.; Eblen-Zajjur, A.; Vasquez, E., 1997:
PAG-microinjected dipyrone (metamizol) inhibits responses of spinal dorsal horn neurons to natural noxious stimulation in rats

Trigon, S.; Paslaru, L.; Morange, M., 1993:
PAGE conditions allowing the identification of the residues phosphorylated by HS-CTD kinase

Brinkmann, U.; Vasmatzis, G.; Lee, B.; Yerushalmi, N.; Essand, M.; Pastan, I., 1998:
PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus

Mcdonald, P., P.; Almond, R., E.; Mapes, J., P.; Friedman, S., B., 1994:
PAH RIS-c soil test: A rapid, on-site screening test for polynuclear aromatic hydrocarbons in soil

Cecinato, A.; Ciccioli, P.; Brancaleoni, E.; Zagari, M., 1998:
PAH and N-PAH in the urban atmosphere of Rome and Milan

Tsai, J.-Horng; Peng, B.-Hwa; Lee, D.-Zang; Lee, C.-Chang, 1995:
PAH characteristics and genotoxicity in the ambient air of a petrochemical industry complex

La Rocca, C.; Conti, L.; Crebelli, R.; Crochi, B.; Iacovella, N.; Rodriguez, F.; Turrio-Baldassarri, L.; di Domenico, A., 1996:
PAH content and mutagenicity of marine sediments from the Venice lagoon

Romano, V.; Guldberg, P.; Guttler, F.; Meli, C.; Mollica, F.; Pavone, L.; Giovannini, M.; Riva, E.; Biasucci, G.; Luotti, D.; Palillo, L.; Cali, F.; Ceratto, N.; Anello, G.; Bosco, P., 1996:
PAH deficiency in Italy: Correlation of genotype with phenotype in the Sicilian population

Mi, H.H.uan; Lee, W.J.y; Wu, T.L.n; Lin, T.C.ang; Wang, L.C.i; Chao, H.R.n, 1996:
PAH emission from a gasoline-powered engine

Yang, H.H.ien; Lee, W.J.y; Chen, S.J.n; Lai, S.O.n, 1998:
PAH emission from various industrial stacks

Yang, H.H.ien; Lee, W.J.y; Mi, H.H.uan; Wong, C.H.; Chen, C.B.ng, 1998:
PAH emissions influenced by Mn-based additive and turbocharging from a heavy-duty diesel engine

Nowacki, P.M.; Byck, S.; Prevost, L.; Scriver, C.R., 1998:
PAH Mutation Analysis Consortium Database: 1997. Prototype for relational locus-specific mutation databases

Hoang, L.; Byck, S.; Prevost, L.; Scriver, C.R., 1996:
PAH Mutation Analysis Consortium Database: a database for disease-producing and other allelic variation at the human PAH locus

Chatsudthipong, V.; Dantzler, W.H., 1992:
PAH/alpha-KG countertransport stimulates PAH uptake and net secretion in isolated rabbit renal tubules

Gardner, B.; Hewitt, C.N.; Jones, K.C., 1995:
PAHs in Air Adjacent to Two Inland Water Bodies

Cousins, I., T.; Kreibich, H.; Hudson, L., E.; Lead, W., A.; Jones, K., C., 1997:
PAHs in soils: Contemporary UK data and evidence for potential contamination problems caused by exposure of samples to laboratory air

Gruden, G.; Cavallo-Perin, P.; Bazzan, M.; Stella, S.; Vuolo, A.; Pagano, G., 1994:
PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria

Mansfield, M.W.; Stickland, M.H.; Grant, P.J., 1997:
PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations

Staiano-Coico, L.; Carano, K.; Allan, V.M.; Steiner, M.G.; Pagan-Charry, I.; Bailey, B.B.; Babaar, P.; Rigas, B.; Higgins, P.J., 1996:
PAI-1 gene expression is growth state-regulated in cultured human epidermal keratinocytes during progression to confluence and postwounding

van Giezen, J.J.; Nerme, V.; Abrahamsson, T., 1998:
PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood

Margaglione, M.; Cappucci, G.; d'Addedda, M.; Colaizzo, D.; Giuliani, N.; Vecchione, G.; Mascolo, G.; Grandone, E.; Di Minno, G., 1998:
PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants

Handt, S.; Jerome, W.G.; Braaten, J.V.; Lewis, J.C.; Kirkpatrick, C.J.; Hantgan, R.R., 1994:
PAI-1 released from cultured human endothelial cells delays fibrinolysis and is incorporated into the developing fibrin clot

Krishnamurti, C.; Keyt, B.; Maglasang, P.; Alving, B.M., 1996:
PAI-1-resistant t-PA: low doses prevent fibrin deposition in rabbits with increased PAI-1 activity

Manser, E.; Loo, T.H.n; Koh, C.G.e; Zhao, Z.S.en; Chen, X.Q.n; Tan, L.; Tan, I.; Leung, T.; Lim, L., 1998:
PAK kinases are directly coupled to the PIX family of nucleotide exchange factors

Obermeier, A.; Ahmed, S.; Manser, E.; Yen, S.C.; Hall, C.; Lim, L., 1998:
PAK promotes morphological changes by acting upstream of Rac

Thiagalingam, S.; Kinzler, K.W.; Vogelstein, B., 1995:
PAK1, a gene that can regulate p53 activity in yeast

Panagiotidis, C.A.; Silverstein, S.J., 1995:
PALEX, a dual-tag prokaryotic expression vector for the purification of full-length proteins

Ford, J., H.; Maccormac, L.; Hiller, J., 1994:
PALS (pregnancy and lifestyle study): Association between occupational and environmental exposure to chemicals and reproductive outcome

Kwon, T.J.n; Young, D.L.; Young, F.L.; Boerboom, C.M., 1998:
PALWEED:WHEAT II: Revision of a weed management decision model in response to field testing

Berge, A.; Sjöbring, U., 1993:
PAM, a novel plasminogen-binding protein from Streptococcus pyogenes

Kanazawa, H.; Kamoi, H.; Kawaguchi, T.; Shoji, S.; Fujii, T.; Kudoh, S.; Hirata, K.; Yoshikawa, J., 1997:
PAMP is a novel inhibitor of the tachykinin release in the airway of guinea pigs

Hu, Z.; Seliskar, C.J.; Heineman, W.R., 1998:
PAN-incorporated Nafion-modified spectroscopic graphite electrodes for voltammetric stripping determination of lead

Brown, C.E.; Tarun, S.Z.; Boeck, R.; Sachs, A.B., 1996:
PAN3 encodes a subunit of the Pab1p-dependent poly(A) nuclease in Saccharomyces cerevisiae

Garvey, M.A.; Giedd, J.; Swedo, S.E., 1998:
PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever

Connelly, M.A.; Grady, R.C.; Mushinski, J.F.; Marcu, K.B., 1994:
PANG, a gene encoding a neuronal glycoprotein, is ectopically activated by intracisternal A-type particle long terminal repeats in murine plasmacytomas

Thomaseth, Karl, 1994:
PANSYM: A symbolic equation generator for mathematical modelling, analysis and control of metabolic and pharmacokinetic systems

Altshuller, A.P., 1993:
PANs in the atmosphere

Iovanna, J.L.; Keim, V.; Bosshard, A.; Orelle, B.; Frigerio, J.M.; Dusetti, N.; Dagorn, J.C., 1993:
PAP, a pancreatic secretory protein induced during acute pancreatitis, is expressed in rat intestine

Sherman, M.E.; Mango, L.J.; Kelly, D.; Paull, G.; Ludin, V.; Copeland, C.; Solomon, D.; Schiffman, M.H., 1994:
PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma

Sturgis, C., D.; Isoe, C.; Mcneal, N., E.; Yu, G., H.; Defrias, D., V.S., 1998:
PAPNET computer-aided rescreening for detection of benign and malignant glandular elements in cervicovaginal smears: A review of 61 cases

Solomon, H.M.; Frist, S., 1998:
PAPNET testing for HSILs. The few cell/small cell challenge

Denaro, T.J.; Herriman, J.M.; Shapira, O., 1997:
PAPNET Testing System. Technical update

O'leary, T.J.; Tellado, M.; Buckner, S.B.th; Ali, I.S.; Stevens, A.; Ollayos, C.W., 1998:
PAPNET-assisted rescreening of cervical smears. Cost and accuracy compared with a 100 percent manual rescreening strategy

Ryan, M.R.; Stastny, J.F.; Remmers, R.; Pedigo, M.A.; Cahill, L.A.; Frable, W.J., 1996:
PAPNET-directed rescreening of cervicovaginal smears: a study of 101 cases of atypical squamous cells of undetermined significance

Husain, O.A.; Kocjan, G.; Butler, E.B.; McGloin, J.E., 1997:
PAPNET. The human and other dimensions

Aleman, C.; Casanovas, J.; Galembeck, S., E., 1998:
PAPQMD parametrization of molecular systems with cyclopropyl rings: Conformational study of homopeptides constituted by 1-aminocyclopropane-1-carboxylic acid

Aleman, C.; Orozco, M., 1994 :
PAPQMD/AM1 parametrization of the bonded term of aromatic biomolecules

Bolsenga, S.J.; Evans, M.; Vanderploeg, H.A.; Norton, D.G., 1996:
PAR transmittance through thick, clear freshwater ice

Boyd, L.; Guo, S.; Levitan, D.; Stinchcomb, D.T.; Kemphues, K.J., 1996:
PAR-2 is asymmetrically distributed and promotes association of P granules and PAR-1 with the cortex in C. elegans embryos

Morioka, N.; Ozaki, M.; Matsukawa, T.; Suzuki, H., 1998:
PARAGRAPH as a neuromuscular blockade monitor

Dettmer, K.; Stieglitz, L., 1994:
PARC. An automated apparatus for clean-up procedures used in routine-analysis for PCDD/PCDF and related compounds

Poltronieri, P.; Yokota, T.; Koyama, Y.; Hanai, S.; Uchida, K.; Miwa, M., 1997:
PARP cleavage in the apoptotic pathway in S2 cells from Drosophila melanogaster

Wang, Z.Q.; Stingl, L.; Morrison, C.; Jantsch, M.; Los, M.; Schulze-Osthoff, K.; Wagner, E.F., 1997:
PARP is important for genomic stability but dispensable in apoptosis

Urményi, T.P.; Van der Ploeg, L.H., 1995:
PARP promoter-mediated activation of a VSG expression site promoter in insect form Trypanosoma brucei

Lundberg, G.; Wahlberg, E.; Rickberg, A.; Olofsson, P., 1995:
PAS-Port: a new implantable vascular access device for arm placement: experiences from the first two years

Van der Leij, I.; Franse, M.M.; Elgersma, Y.; Distel, B.; Tabak, H.F., 1993:
PAS10 is a tetratricopeptide-repeat protein that is essential for the import of most matrix proteins into peroxisomes of Saccharomyces cerevisiae

Marzioch, M.; Erdmann, R.; Veenhuis, M.; Kunau, W.H., 1994:
PAS7 encodes a novel yeast member of the WD-40 protein family essential for import of 3-oxoacyl-CoA thiolase, a PTS2-containing protein, into peroxisomes

Deary, I.J.; Ebmeier, K.P.; Macleod, K.M.; Dougall, N.; Hepburn, D.A.; Frier, B.M.; Goodwin, G.M., 1994:
PASAT performance and the pattern of uptake of 99mTc-exametazime in brain estimated with single photon emission tomography

Chang, F.C.; Harrison, P.B.; Beech, R.R.; Helmer, S.D., 1995:
PASG: does it help in the management of traumatic shock?

Kleinhenz, B.; Joerg, E.; Gutsche, V.; Kluge, E.; Rossberg, D., 1996:
PASO-computer-aided models for decision making in plant protection

Cousineau, D.; Larochelle, S., 1997:
PASTIS: A program for curve and distribution analyses

Lin, R.; Allis, C.D.vid; Elledge, S.J., 1996:
PAT1, an evolutionarily conserved acetyltransferase homologue, is required for multiple steps in the cell cycle

Buchholz, B.; Paquet, V.; Punnett, L.; Lee, D.; Moir, S., 1996:
PATH: A work sampling-based approach to ergonomic job analysis for construction and other non-repetitive work

Neuhann, H.-Florian; Praetor, K.; Szemkus, M.; Wiesmueller, G.-Andreas; Schlipkoeter, H.-Werner, 1992:
PATIS: A questionnaire-based, PC-assisted patient-information-system in environmental medicine

Esposito, C.; Miccadei, S.; Saiardi, A.; Civitareale, D., 1998:
PAX 8 activates the enhancer of the human thyroperoxidase gene

Hol, F.A.; Geurds, M.P.; Chatkupt, S.; Shugart, Y.Y.; Balling, R.; Schrander-Stumpel, C.T.; Johnson, W.G.; Hamel, B.C.; Mariman, E.C., 1996:
PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida

Gérard, M.; Abitbol, M.; Delezoide, A.L.; Dufier, J.L.; Mallet, J.; Vekemans, M., 1995:
PAX-genes expression during human embryonic development, a preliminary report

Schnittger, S.; Rao, V.V.N.G.pal; Deutsch, U.; Gruss, P.; Balling, R.; Hansmann, I., 1992:
PAX1, a member of the paired box-containing class of developmental control genes, is mapped to human chromosome 20p11.2 by in situ hybridization (ISH and FISH)

Burrill, J.D.; Moran, L.; Goulding, M.D.; Saueressig, H., 1997:
PAX2 is expressed in multiple spinal cord interneurons, including a population of EN1+ interneurons that require PAX6 for their development

Tassabehji, M.; Newton, V.E.; Leverton, K.; Turnbull, K.; Seemanova, E.; Kunze, J.; Sperling, K.; Strachan, T.; Read, A.P., 1994:
PAX3 gene structure and mutations: Close analogies between Waardenburg syndrome and the Splotch mouse

Prosser, J.; van Heyningen, V., 1998:
PAX6 mutations reviewed

Poleev, A.; Fickenscher, H.; Mundlos, S.; Winterpacht, A.; Zabel, B.; Fidler, A.; Gruss, P.; Plachov, D., 1992:
PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors

Dehbi, M.; Pelletier, J., 1996:
PAX8-mediated activation of the wt1 tumor suppressor gene

Nuttley, W.M.; Brade, A.M.; Eitzen, G.A.; Veenhuis, M.; Aitchison, J.D.; Szilard, R.K.; Glover, J.R.; Rachubinski, R.A., 1994:
PAY4, a gene required for peroxisome assembly in the yeast Yarrowia lipolytica, encodes a novel member of a family of putative ATPases

Bollag, B.; Frisque, R.J., 1992:
PAb 2000 specifically recognizes the large T and small t proteins of JC virus

Hess, R.; Oberbeck, J.; Grussenmeyer, T.; Schoeffel-Keller, A.; Haessler, C.; Braun, D.G.; Brandner, G., 1994:
PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus, and other JC virus tumor antigen cross-reactive antibodies of the PAb1601-1636 panel

Baumbard, P.; Budzinski, H.; Garrigues, P., 1998:
PAhs in Arcachon Bay, France: Origin and biomonitoring with caged organisms

Beljanski, M.; Crochet, S.; Beljanski, M.S., 1993:
PB-100: a potent and selective inhibitor of human BCNU resistant glioblastoma cell multiplication

Fang, N.; Teal, P., E.A.; Tumlinson, J., H., 1995:
PBAN regulation of pheromone biosynthesis in female tobacco hornworm moths, Manduca sexta (L.)

van Engelen, F.A.; Molthoff, J.W.; Conner, A.J.; Nap, J.P.; Pereira, A.; Stiekema, W.J., 1995:
pBINPLUS: an improved plant transformation vector based on pBIN19

O'flaherty, Ellen, J., 1995:
PBK modeling for metals: Examples with lead, uranium, and chromium

Perrakis, A.; Constantinides, C.; Athanasiades, A.; Hamodrakas, S.J., 1995:
PBM: A software package to create, display and manipulate interactively models of small molecules and proteins on IBM-compatible PCs